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Abstract
Alzheimer's disease is a progressive neurological ailment affecting 4.5 million
aging Americans. The disease is characterized by the presence in the brain of selfassembled fibrils consisting of beta amyloid protein (Aβ). Soluble Aβ protein is present
in normal human cerebrospinal fluid, but it is unclear what makes the protein aggregate
into insoluble plaques. There is evidence that the Aβ fibril assembly is affected by
interactions with biological surfaces, such as neuronal membranes.

Here, surfaces

consisting of self-assembled alkanethiol monolayers with different end groups were used
to test the effect of surface chemistry on the structure and morphology of aggregates
formed from the Aβ peptide. Reflection-absorption infrared spectroscopy and scanning
force microscopy (SFM) were used to examine the interactions of the protein with the
monolayers. It was found that the surfaces have a seeding effect on the Aβ protein in
solution and can actually induce aggregation of the Aβ protein over time. The outcomes
are important, because the work described here is the first attempt at relating the chemical
makeup of supported, model monolayer surfaces and their propensity to interact with Aβ
peptide in solution. Patterned surfaces consisting of fouling and non-fouling monolayers
were constructed to determine how these different areas would affect the deposition and
aggregation of the Aβ protein. It appeared that the Aβ protein adsorbed onto the ethylene
glycol even though the ethylene glycol-terminated monolayers alone were previously
seen to be non-fouling. This was important because it appears that the fouling monolayer
can induce a change in conformation that allows the protein to stick to what are normally
non-fouling surfaces.
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Mica-supported lipid bilayers consisting of 1-Palmitoyl-2-Oleoyl-sn-Glycero-3Phosphocholine

(POPC)

and

1-Oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-

yl)amino]dodecanoyl]-sn-Glycero-3-Phosphocholine (NBD-PC) were also used as a
simple cell membrane model system. Fluorescence photobleaching recovery and SFM
were used to determine the effects of association of the fibrils with the bilayers. It was
found that the Aβ peptide affected the fluidity of the lipid bilayers and inserted itself into
the lipid bilayer. This experiment was important because it offers information about the
insertion of the Aβ peptide into cell membranes that could potentially be toxic to cells.
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Chapter 1
Goals, Research Synopsis, and Background

1.1

Research Goals and Aims
The goal of this research project is to understand the effects of surface chemistry on the

aggregation of beta amyloid (Aβ) peptide in solution using self-assembled monolayers and lipid
bilayers as models of biological surfaces. This is an important research area because the Aβ
peptide is directly linked to Alzheimer’s disease. Surfaces of self-assembled, ω-substituted
alkanethiol monolayers supported on Au were used to test the influence of different types of
chemical moieties on Aβ peptide aggregation. Aβ peptide in solution was incubated with the
monolayers to determine the possible impact of the monolayers on the aggregation of Aβ.
Reflection-absorption infrared spectroscopy was used to provide information on the deposition
of Aβ peptide onto the monolayers and the conformation of the protein deposits. Scanning force
microscopy was used to obtain additional information about the morphology of Aβ aggregates.
Patterned, self-assembled monolayers consisting of two different types of chemical end groups
were used to determine the effects of the combination on the Aβ peptide aggregation. Lipid
bilayer surfaces were also incubated with Aβ peptide solutions to determine any possible
interactions between the two entities. Fluorescence photobleaching recovery and fluorescence
microscopy were used to evaluate the effect of Aβ protein on the lipid bilayers. The specific
aims of this work included:
•

Determine which monolayers adsorb Aβ peptide

•

Verify the conformation of the adsorbed Aβ peptide

•

Determine the extent of Aβ aggregation and aggregate size

1

•

Establish whether the monolayers have a seeding affect on the aggregation of Aβ peptide
in solution

•

Determine whether patterned monolayer surfaces consisting of two different alkanethiols
promote deposition and aggregation of the Aβ peptide differently than from the singleconstituent monolayers

•
1.2

Ascertain the effect that Aβ protein has on the fluidity of the lipid bilayers.
Research Synopsis
The purpose of this research plan is to discover the effects of surface chemistry on the

aggregation of beta amyloid (Aβ) peptide, the protein that is the hallmark of Alzheimer’s disease.
It is not precisely known why Aβ peptide aggregates in vivo, but it is speculated that it coincides
with the environment surrounding the Aβ peptide in the human body as shown in Figure 1.1.
Surfaces of supported self-assembled monolayers with chemically different end groups were
used to test this theory. It was determined that the deposition of Aβ peptide onto the monolayers
and subsequent aggregation corresponded to the type of end groups on the monolayers and the

Figure 1.1. Synopsis and motivation of research.
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properties, such as the hydrophobicity or hydrophilicity, of the end groups.

It was also

determined whether Aβ peptide has an affinity for certain functional groups on the surfaces and
what the conformation of the adsorbed Aβ peptide was. The strategy to understanding this
problem was to fabricate surfaces and let Aβ protein incubate on them. Initial analysis by
reflection-absorption infrared spectroscopy was done to reveal possible deposition of Aβ peptide
to the surface and the conformation of the peptide. Subsequent analysis by scanning force
microscopy was done to determine the size and extent of aggregation. Combinations of different
types of monolayers patterned on the same surface were also analyzed. Lipid bilayer surfaces
were also used as a simplified cell membrane model. Aβ protein solution was incubated on the
fluorescent-tagged lipid bilayers to determine the effect that the Aβ protein would have on the
lipid bilayer fluidity, which was analyzed with fluorescence photobleaching recovery. This
study gave information about possible insertion of the Aβ protein into the lipid bilayer, which
could provide knowledge about the toxicity of the Aβ peptide. Fluorescence microscopy and
scanning force microscopy were employed to image the Aβ peptide on the lipid bilayers.
1.3

Background

1.3.1

History of Alzheimer’s Disease

Alzheimer’s disease is a neurological ailment characterized by plaques and neurofibrillary
tangles in the brains of humans. Alois Alzheimer first noted the disease in 1907.1 Scientists
estimate that around 4.5 million people in the US and 24 million people worldwide have AD.2
The disease outwardly manifests itself with disorientation, memory loss, mental regression, and
eventually death of the human. Autopsies on the brains of humans afflicted with Alzheimer’s
disease reveal neurodegeneration, atrophy of the frontal, temporal, and parietal cortex, and
extracellular deposition of fibrillar structures, called amyloid plaques, in the cerebral

3

vasculature.3 These amyloid plaques are thought to be a contributor to the pathogenesis of
Alzheimer’s disease, and there is a direct correlation between the amount of amyloid plaque and
the severity of the symptoms of the disease.4

The deposits were originally isolated and

characterized by amino acid analysis in 1984.5 The major component of these ordered protein
aggregates is the Aβ peptide.
1.3.2

Beta Amyloid Precursor Protein
The genesis of the amyloid deposits have been the focus of a large amount of research

effort.4 The Aβ peptide originates from a group of 695-770 amino acid residues called the beta
amyloid precursor protein (APP),6 a normal transmembrane glycoprotein that is generated by the
endoplasmic reticulum of the cell.7

APP is normally found in brain cell membranes and the

functions of APP include maintaining connections between brain cell, aiding in the growth and
repair of brain cells and promoting cell adhesion.8 The soluble Aβ peptide is produced during
normal cellular metabolism when the APP is cleaved.9 There are two different pathways by
which the APP is cleaved to form the Aβ peptide. In the exocytotic processing path, the APP
undergoes normal proteolytic cleavage by α-secretase as it is released from the cell membrane.10
In the endocytotic route, the APP is cleaved within the cell membrane by β- and γ- secretase.11
This proteolytic processing forms the Aβ peptide.
1.3.3

Beta Amyloid Peptide in the Body
Aβ peptide is an amphiphilic peptide made up of 39-43 amino acid residues with a

hydrophilic N-terminus and a hydrophobic C-terminus.12 The Aβ protein has an assortment of
physiological functions. In humans, these roles include modulating synaptic function, aiding in
neuronal growth and survival, shielding against oxidative damage of cerebrospinal fluid and
plasma lipoproteins, and surveillance against neuroactive compounds and toxins.13 The Aβ
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peptide is commonly found in the cerebrospinal fluid and plasma of normal humans in the
soluble form.14-16 Due to unknown causes, the Aβ peptide folds into β-sheet structures in the
brain of Alzheimer’s disease victims which lead to the formation of insoluble aggregates and
fibrils17, 18 that are toxic to neuronal cells.19, 20
1.3.4

Effects of Beta Amyloid Plaques
Insoluble Aβ protein has a detrimental effect on the human brain. The Aβ aggregates

have been shown to alter the mitochondrion of brain cells, which, in turn, causes swelling and
inflammation of the brain.21 It has been demonstrated that the organized Aβ structures with βsheet conformation disrupt cell membranes and cause homeostasis malfunctions and the
interruption of cellular signals.7, 22, 23 Aβ plaques also destroy synapse by inducing oxidative
damage to the synapse membrane.24 Neurons are also damaged when the Aβ structures form ion
channels that allow for the uptake of calcium which causes instability in the normal cellular
homeostasis.25 All of these processes combine and lead to degradation of the brain, mental
dementia, and death of the human.
1.3.5

Surface-Induced Aggregation of Beta Amyloid Peptide
There is evidence that Aβ fibril assembly is dependent on interactions with biological

surfaces, such as membranes.26-28 It has been shown that the presence of negatively charged
lipid vesicles in Aβ solutions shifts the normal random coil conformation of Aβ peptide to a βsheet conformation under conditions of low ionic strength.26, 27 This is due to the electrostatic
binding of Aβ peptide onto the lipid membrane surface and subsequent aggregation of the
peptide.28 The use of solid state 31P NMR and circular dichroism in solution have demonstrated
that the composition of lipid bilayers in vesicles (fraction of charged and uncharged lipids) has a
profound impact on the ability of the vesicle-based lipid bilayers to extract the Aβ peptide from
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solution and increase is local concentration in the lipid bilayer and initiate random-coil to β-sheet
conformational changes of monomeric Aβ1-40 in aqueous solution.29 Consequently, it is possible
that some type of moiety on the cell surface triggers the folding of Aβ peptide and subsequent
plaque formation. Therefore, it is important to investigate the influence of surface chemistry on
the aggregation of the Aβ peptide.
1.3.6

Self-Assembled Monolayers as Model Surfaces
A model system was chosen to determine the possible effects of surface chemistry on the

aggregation of Aβ peptide.

Self-assembled monolayers (SAMs) consisting of chemically

modified alkanethiol chains on gold substrates were chosen to mimic these biological surfaces.
These model surfaces were used to determine the effect of surface chemistry on the binding and
nucleation of the Aβ peptide.

The SAMs imitate small unilamellar lipid vesicles and form a

stable, ordered surface in which the end groups of the monolayer can be modified. It is proposed
that the different end groups of the alkanethiol chains will have an effect on the extent and speed
of aggregation of the Aβ peptide. Studies of the deposition of the peptide onto the different
monolayer surfaces have been conducted. Reflection-absorption infrared spectroscopy (RAIRS)
and scanning force microscopy (SFM) were used to analyze deposition of the Aβ protein on the
monolayer surfaces. The effects of the monolayers on the Aβ protein in solution were also
analyzed.
1.3.7

Properties of Self-Assembled Monolayers
Several ω-substituted alkanethiol monolayers on Au were investigated, such as

monolayers with methyl (HS-(CH2)17-CH3), alcohol (HS-(CH2)11-OH), carboxylic acid (HS(CH2)15-COOH), fluorine (HS-(CH2)2-(CF2)7-CF3), and sulfonic acid (HS-(CH2)10-SO3H)
functionalities. Gold was chosen as the supporting substrate because it possesses a clean,

6

ordered surface that allows for the orderly formation of subsequent monolayers. The surface of
the gold is arranged in a (111) cubic lattice formation.

The packing order and angle of

attachment of the monomer units of the monolayer depend on the structure of the monomer
chain, the interactions between monomer nearest neighbors, and interactions between the
monomer units and the lattice surface of the gold.30 The angle of attachment of the monolayers
to the surface is approximately 30˚ with respect to the normal.30

The thickness of the

monolayers ranges from 10-25 Å depending on the chain length and the angle of attachment.31
The chains that are more bulky, such as the carboxylic acid chains and the sulfonic acid chains,
have higher angles of attachment with respect to the normal and are less thick when compared to
unsubstituted alkanethiols with the same chain length. The fluorinated monolayer forms a
hexagonal lattice with approximately 5.8 Å distance between each chain.32 The methyl
monolayer is also in a hexagonal lattice but has a spacing of 5.0 Å between the chains because
the unsubstituted alkanethiol chains are less bulky than the fluorinated alkanethiol monolayer.33
The carboxylic acid monolayer forms a double row configuration on the Au substrate. 34
1.3.8

Relationship of Self-Assembled Monolayers to Biological Surfaces
Self-assembled monolayers were chosen because of the wide varieties of surface

functionalities available that correspond to different biological moieties found in the human
brain. The carboxylic acid- and alcohol-terminated functionalities produce hydrophilic
monolayers on Au that are highly polar and have high surface energies. They are used to model
the phospholipid bilayers found in cell membranes with hydrogen bonding capabilities. The
unsubstituted alkanethiol produces a hydrophobic, nonpolar monolayer with a low surface
energy, which can also be used to model cell membranes. In addition, the hydrophilic sulfonic
acid-terminated monolayer is similar to heparin from a charged functional group point of view,
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because the heparin molecule has sulfonic acid functionalities along the protein backbone.35 It
has been shown that heparin interacts with the Aβ peptide.36-38 Finally, the fluoro-methyl
monolayer is a very hydrophobic, Teflon-like molecule that is analogous to the apolar side of the
cell membrane; this is an important parallel because it is thought that when the amyloid
precursor protein is cleaved within the membrane the toxic species of Aβ is produced. 39, 40
1.3.9

Patterned Self-assembled Monolayers
Microcontact printing of alkanethiols was developed by the Whitesides group at Harvard

in 1993.41 The process is a type of soft lithography that involves using a stamp, usually
polydimethyl siloxane (PDMS), to transfer an alkanethiol pattern to a metal surface followed by
backfilling the bare areas by solution deposition of a different ω-terminated alkanethiol solution.
This method is commonly used to study the interaction of proteins at interfaces and to
immobilize proteins for various types of detection.
PDMS is a preferred polymer for stamps because it is a durable material that can be
reused many times. It also offers a chemically inert, flexible surface with low surface free
energy.42 The stamp is “inked” by applying a drop of alkanethiol solution to the stamp, allowing
the alkanethiol to absorb into the PDMS for a brief amount of time and then drying the stamp
with nitrogen. Drying the stamp prevents smearing of the pattern and preserves the arrangement
of the microcontact printed alkanethiol by reducing the diffusion effects that occur after the
imprinting is done. Using a dry stamp circumvents this process by printing the vapor phase
molecules trapped in the stamp.42 Even though the stamp is dried, ethanol and alkanethiol are
still present on and in the stamp after drying the stamp because the small amounts of the solution
are absorbed into the bulk part of the poly siloxane matrix. The amount of alkanethiol present in
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the stamp reflects the permeability of the PDMS stamp and the structure of the alkanethiol and
solvent.43
The inherent process of autophobic pinning also helps keep the pattern clean by reducing
diffusion of the alkanethiol. Autophobic pinning occurs when a liquid in contact with a surface
alters the chemistry of this surface and lowers its solid-vapor surface tension and solid-liquid
surface tension, and the liquid edge retracts automatically back to the shape of the stamp.44 The
formation of a self-assembled monolayer on gold by autophobic pinning is exothermic.45
Initially the alkanethiols are disordered on the gold surface, and as the alkanethiols find their
places on the gold lattice the monolayer becomes ordered. Once the ordered monolayer forms,
the drop edge of the monolayer spontaneously retracts to the original shape of the stamp.
1.3.10 Ethylene Glycol-Terminated Alkanethiols
Poly(ethylene glycol) has been used since the early 1980s.46 Poly(ethylene glycol) is
well known to be protein resistant.
resistance.

The steric repulsion model can explain this protein

As the protein moves toward the surface of the poly(ethylene glycol), the

poly(ethylene glycol) chains collapse which causes steric repulsion with the protein.47 This
process is applicable for long polyethylene glycol chains. For shorter chains of oligo(ethylene
glycol) monolayers, protein resistance is contributed to the water at the protein-oligo(ethylene
glycol) interface.48 This is known as the water barrier theory. The water molecules are tightly
bound to the oligo(ethylene glycol) surface such that the protein cannot adsorb to the
oligo(ethylene glycol). Self-assembled monolayers with two repeat units of ethylene glycol do
adsorb protein due to a more densely packed monolayer, which prevents the water attachment to
the ethylene glycol units.49 Oligo(ethylene glycol) chains with six monomer repeat units seem to
be the most protein resistant in all assembly solvents because the oligo(ethylene glycol)
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monomer has a lower packing density, which allows the water to fully surround the ethylene
glycol chain, thereby preventing adsorption of hydrophilic proteins.
Although ethylene glycol end groups are usually known to be non-fouling, a few
examples in the literature show protein to be attracted to ethylene glycol functionalities.
Leckband et al. discovered that if streptavidin was forced into contact with a poly(ethylene
glycol) chain, there existed reasonably strong attractive forces between the protein and the
poly(ethylene glycol) moiety.50 It has also been shown that mucin, glycoproteins that line the
gastrointestinal tract, adhere weakly to poly(ethylene glycol).51 Ethylene glycol surfaces that
have fouling properties can arise by increasing the compression rates or temperature of the
system, or by varying the polymer molecular weight.52
1.3.11 Lipid Bilayers as Model Surfaces
Mica-supported

lipid

bilayers

consisting

of

1-palmitoyl-2-oleoyl-sn-glycero-3-

phosphocholine (POPC) and 1-oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino] dodecanoyl]-sn-glycero-3-phosphocholine (NBD-PC) (Figure 1.2) were used as a simplified cell
membrane model system. Lipid bilayers are physiologically significant because phospholipids
are principle components of cellular membranes and POPC is one of the main elements of
mammalian cell membranes.53, 54 These model surfaces were used to determine the effect of the
Aβ peptide on the fluidity of the lipid bilayers. Cell membranes in the body are fluid to allow for
the exchange of vital substance, such as nutrients and waste, into and out of the cell. This
experiment is important because it gives information about the insertion and binding of the Aβ
peptide into cell membranes that could disrupt this cellular homeostasis, which would be
potentially toxic to cells.
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Figure 1.2. Chemical structures of (A) 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) and (B) 1-oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino] dodecanoyl]-snglycero-3-phosphocholine (NBD-PC).
1.3.12 Interaction of Beta Amyloid Protein with Lipid Membranes
Previous studies have shown that Aβ protein interacts with lipid bilayers and cell
membranes. Aβ peptide alters the fluidity of cell membranes such as synaptosomal plasma and
mitochondrial membranes as shown by polarized fluorescence microscopy.55

It has also been

shown that the presence of Aβ peptide aggregates causes a decrease in fluidity of POPC bilayers
as inferred by changes in anisotropy of the bilayer.56 Solution NMR and circular dichroism have
also been used to track the interaction of Aβ peptide in lipid environments. These studies
demonstrated a conformation change from α-helical monomer to β-sheet fibrils that was induced
by molecular structural characteristics of the membrane.57 Solid-state NMR confirmed that Aβ
peptide binds to the lipid vesicles and X-ray spectroscopy has shown that Aβ peptide inserts into
the lipid bilayers.58, 59
There is evidence that the interaction of Aβ peptide with lipid vesicles is a result of
electrostatic interactions. Aβ peptide inserts into normal phospholipid bilayers, but when they

11

are compressed the Aβ peptide is expelled completely from zwitterionic bilayers, such as 1,2dipalmitoylphosphatidylcholine (DPPC), while the Aβ peptide remains inserted in the negatively
charged bilayers, such as 1,2-dipalmitoylphosphatidylglycerol (DPPG).60

It was further

determined that the DPPG promotes seeding and aggregation of the Aβ peptide on the lipid
bilayer, while DPPC and dipalmitoyl trimethyl ammonium propane (DPTAP), a positivelycharged lipid, inhibit the aggregation of Aβ peptide.59
It was first reported that cell membranes in the presence of Aβ peptide showed defects in
their surfaces.7 This led to further investigations regarding the interactions of cell membranes
and model lipid bilayers with Aβ peptide. It was next determined that the gangliosides-bound
Aβ peptide in the lipid bilayers experienced a conformation change from random coil structure to
β-sheet structure.61

It was later found that upon binding to cell membranes containing

gangliosides, the Aβ peptide showed seeding capabilities that promoted further aggregation of
the Aβ peptide.62 It was initially proposed that the interaction of the Aβ peptide with lipids did
not rely on charge-charge interactions, but were a result of the hydrophobic areas of the Aβ
peptide interacting with the hydrophobic core of the lipid bilayers.63 It was also found that the
presence of cholesterol in the lipid membranes attracts the Aβ peptide and helps immobilize the
Aβ peptide on the lipid membrane, which promotes the fibrillogenesis of the Aβ peptide.64 The
use of
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P magic angle spinning NMR demonstrated that in addition to the initial hydrophobic

interaction of the Aβ peptide with the lipid bilayer there exists an electrostatic component to the
interaction.65 Solid state 31P NMR was used to further confirm that the adsorption of Aβ peptide
to lipid membrane is due to electrostatic mechanisms by demonstrating that the Aβ peptide fuses
with lipid membranes containing different charged headgroups.58 In addition to disrupting the
membrane fluidity, the Aβ peptide also generates the leakage of the contents of lipid vesicles;
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which, in turn, could be correlated to the neurotoxicity of the Aβ peptide.56 Further studies
comparing the type of Aβ peptide that interacts with the lipid bilayers found that the fibrillar Aβ
peptide greatly reduced the fluidity of the lipid bilayers, while the monomeric, or unaggregated,
Aβ peptide had a much smaller effect on the fluidity of the lipid bilayers.66 With the discovery
that the soluble Aβ peptide oligomers were the most likely toxic species of protein, research
shifted its focus towards analyzing the smaller Aβ peptide aggregates.67 It was determined that
the oligomeric Aβ peptide changed the molecular structure of the lipid membranes which
induced a conformational change of the Aβ peptide from the α-helix conformation to the toxic βsheet conformation.57
1.3.13 Techniques Used to Verify Protein Deposition and Aggregation
Reflection-absorption infrared spectroscopy (RAIRS) was chosen to analyze the
interaction between the supported ω-substituted alkanethiol monolayers and the monomeric Aβ
peptide. Infrared spectroscopy is a good tool for detecting proteins on surfaces because of the
prominence of the amide I bands at roughly 1600 cm–1 and the amide II bands at roughly 1500
cm–1.68 The position of these bands also reveals information about the conformation of the
peptide. The positions of the amide I and amide II bands for alpha helix conformation, random
coil conformation, and beta structures of peptides are summarized in Table 1.1. 69, 70
RAIRS is performed using p-polarized infrared radiation with the electric field oriented
normal to the surface at a high (grazing) angle of incidence.71 At the high angle, the intensity of
the infrared is optimized so the sub-micromolar quantities of chemical species can be detected.
The transmission of the radiation into the Au layer creates a surface standing wave electric field
that interacts with the vibrational modes of the adsorbates.

The adsorbates must have a

component of their dipole transition oriented normal to the surface, otherwise the infrared
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radiation will not be absorbed.71,

72

Curve-fitting deconvolution of the spectra was used to

resolve overlapped peaks to determine the secondary structure of the protein. Quantification of
the amounts of the various secondary structures cannot be performed due to the selection rules
that apply for RAIRS.71
Table 1.1. Position of amide I and amide II IR bands for different protein conformations.
Beta sheet
conformation
Random coil
conformation
Alpha helix
conformation

Amide I peak position (cm-1)
1625-1640, 1665-1695

Amide II peak position (cm-1)
1530-1535

1650-1655

1545-1550

1645-1650

1548-1553

Scanning force microscopy (SFM) is a useful technique that can provide a variety of
information regarding topography of surfaces. It was chosen to image alkanethiol monolayers
and lipid bilayers upon exposure to Aβ protein to obtain information about the size of protein
species on the different surfaces. SFM will also be used to understand the physical appearance
of the aggregates. When analyzing the patterned monolayers, frictional SFM will be used to
determine the position of the different chemical functionalities on the monolayers.
Fluorescence photobleaching recovery (FPR) was also chosen to evaluate the effect of Aβ
protein on the lipid bilayers.

FPR is a valuable technique that can be used to provide

information regarding the diffusion coefficient and the fluidity of the lipid bilayers.
Fluorescence microscopy and in situ SFM was used in conjunction with FPR to image the
interaction of the Aβ protein with the lipid bilayers.
All of the aforementioned techniques are further described in Chapter 2.
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Chapter 2
Materials and Methods
2.1

Chemicals and Products
Beta amyloid 10-35 [cat # 03-153, lot 0315302, BioSource, 79% peptide content], bovine

serum albumin [CAS # 9048-46-8, Sigma, 96%], HS-(CH2)17-CH3 [CAS # 2885-00-9, Fluka,
95%], HS-(CH2)11-OH [CAS # 73768-94-2, Aldrich, 97%], HS-(CH2)11-(OCH2CH2)3-OH [cat #
TH002-02, lot A2709, ProChimia], 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine in
chloroform [cat # 850457C, lot 160-181PC-138, Avanti Polar Lipids, Inc.], 1-oleoyl-2-[12-[(7nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl] -sn-glycero-3-phosphocholine in chloroform
[cat # 810133C, lot F181-120NBD-24, Avanti Polar Lipids, Inc.], potassium hydroxide [CAS #
1310-58-3, Aldrich, 99.99%], phosphoric acid [CAS # 7664-38-2, Aldrich, 99.99%], and
absolute ethanol [AAPER Alcohol & Chemical Company] were used as received. HS-(CH2)2(CF2)7-CF3 was a gift from Marc Porter at Iowa State University. The HS-(CH2)15-COOH and
HS-(CH2)10-SO3H were synthesized previously.1, 2 The poly(dimethyl siloxane) stamp was a gift
from Yu-Tai Tao at Academia Sinicia in Taipei, Taiwan. Nanopure water was obtained by
passing distilled water through a Barnstead reverse osmosis filter and then through a Nanopure
water system.
2.2

Methodologies

2.2.1

Gold Substrate Formation
Gold substrates for infrared studies were prepared using 1” x 3” glass substrates. The

slides were soaked in isopropanol for 30 minutes and then sonicated in isopropanol for 30
minutes. The slides were then rinsed with Nanopure water followed by an absolute ethanol
rinse. The slides were dried with house nitrogen (liquid nitrogen boil-off) and placed in an
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Edwards Auto 306 Vacuum Coater. Deposition of 15 nm chromium was preformed at 3.0 x 10–7
Torr followed by 200 nm gold at 1.0 x 10–7 Torr. After removal from the evaporator, the
substrates were immediately put in ethanol and purged with N2. The gold substrates for scanning
force microscopy studies were made using freshly cleaved mica with a deposition of 2000 Å
gold.

The gold on mica was then annealed at 400 °C for four hours under atmospheric

conditions. The gold substrates were subsequently cleaned with UV light and then placed in
ethanol.
2.2.2

Monolayer Formation
Au substrates were rinsed with ethanol and placed in 500 μM solutions of HS-(CH2)17-

CH3, HS-(CH2)11-OH, HS-(CH2)2-(CF2)7-CF3, HS-(CH2)15-COOH, HS-(CH2)10-SO3H, or HS(CH2)11-(OCH2CH2)3-OH for a minimum of one hour. After this self-assembly process, the
monolayers on Au were rinsed with ethanol and dried under a stream of N2. The monolayers on
Au were prepared immediately before they were used in experiments.
2.2.3

Patterned Monolayer Formation
Pattering of monolayers was achieved via microcontact printing.3

A poly(dimethyl

siloxane), PDMS, stamp with relief lines ranging from 1μm to 10 μm was used. HS-(CH2)17-CH3
solution (1 mM in ethanol) was applied to the stamp and allowed to absorb for 30 seconds. The
stamp was then dried with N2 and immediately placed on an Au substrate. Gentle pressure was
initially applied to ensure complete contact. After three minutes, the stamp was removed from
the Au, and the Au/patterned monolayer was rinsed with ethanol to remove unbound thiols from
the surface. The sample was then placed in a 1 mM ethylene glycol-terminated solution to allow
self-assembly of the ethylene glycol-terminated alkanethiol in the bare areas to completely fill in
the pattern.
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2.2.4

Lipid Bilayer Formation
Phospholipid vesicles were prepared via the Morrissey Lab Protocol, yielding a 2 mg/mL

concentration.4 Briefly, 1.9 mg POPC and 0.1 mg NBD-PC in chloroform was dispensed into a
13 mm X 100 mm Pyrex test tube. The lipids were dried under N2 until the chloroform was
removed by evaporation. To remove any residual chloroform, the lipids were high vacuumed for
60 minutes. A 2-mL aliquot of pH 7.4, 500 mM phosphate buffer was added to the lipids and the
resulting solution was allowed to sit at room temperature for 60 minutes after which the solution
was vortexed to resuspend the lipids. Two methods of forming small, unilamellar vesicles were
tested. In the first, the lipid solution was sonicated with a micro-tip Branson Sonifier 450 for
five minutes to yield a suspension of small unilamellar vesicles. In the second method, an
extruder was used to form the small unilamellar vesicles. The extrusion method was found to be
superior for forming uniform vesicles.

Figure 2.1

Schematic of vesicle fusion on a hydrophilic surface.
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Lipid bilayers were formed via spontaneous lipid fusion. Briefly, when lipid vesicles
come in contact with a hydrophilic surface, they spontaneously reorder to form lipid bilayers as
depicted in Figure 2.1.5 As the vesicle approaches the surface, electrostatic attractions between
the hydrophilic surface and the vesicle cause the vesicle to spread out onto the surface until the
vesicle burst and flattens out onto the surface to form a lipid bilayer. The vesicle solution was
applied with a pipette onto freshly cleaved mica and allowed to incubate. After 30 minutes, the
mica was rinsed with phosphate buffer. The resulting lipid bilayers were kept moist to prevent
disassembly of the bilayers. The formation of the lipid bilayers was confirmed using height
scanning force microscopy.
2.2.5

Beta Amyloid Solution Preparation
Beta amyloid (10-35) solutions were prepared using 15 mM phosphate buffer (no ionic

strength) and 15 mM PBS/150 mM NaF for experiments at pH 7.4, and 10 mM KOH solution
for experiments at pH 11.5. Lyophilized Aβ10-35 peptide was weighed out into a polypropylene
micro centrifuge tube [cat # RN2000-GMT, Dot Scientific]. The peptide was then dissolved in
one of the above solutions by vortex to give a final peptide concentration of 100 μM. Peptide
concentration was confirmed using amino acid analysis.
2.2.6

Amino Acid Analysis
Peptide concentration of the solutions applied to the supported alkanethiol monolayers

and the supernatant solutions from the alkanethiol monolayers were determined by amino acid
analysis of peptide solution hydrolysates.

Amino acid content was determined by

chromatographic separation with a Dionex 6550 utilizing an anion exchange column and NaOH
gradient, with an electrochemical detector (Dionex ED50). The peptide solution was hydrolyzed
and then injected (4 replicates), and the amino acid content of the individual residues was
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compared to known amounts of standard, such as norleucine. The average value from the 4
replicates was recorded, and it was found that the standard deviation was ±0.01 μM.
2.2.7 Sample Incubation of Beta Amyloid Protein on Supported Alkanethiol Monolayers
For experiments involving the deposition of Aβ10-35 peptide on alkanethiol monolayers,
Aβ10-35 peptide solution was applied onto the monolayers supported on Au to sufficiently cover
the top of the sample, and then the solution-covered monolayers on Au were placed into a
container under humidified N2 (Figure 2.2). The container consisted of a polypropylene jar
(Nalgene, cat # 2118-0016/500ml); the cover was drilled twice and septa were installed. An 18gauge needle was placed in one of the two septa for exhaust; the other septum had a needle
connected to a continuous humidified nitrogen purge. Evaporation of the solution was not
noticed. Samples for RAIRS and SFM were prepared simultaneously and incubated in the same

300 μL
solution
onto
monolayer

Humidified
N2
vent
Rinse with
buffer
solution
Dry with N2

Figure 2.2. Schematic for sample incubation.
container. The Aβ solution was allowed to incubate at room temperature on the monolayers for
15 h.

The Aβ solutions on the HS-(CH2)11-OH, HS-(CH2)2-(CF2)7-CF3, and HS-(CH2)11-

(OCH2CH2)3-OH monolayers were allowed to incubate additionally for 7 days, 20 days, and 40
days. Controls consisted of the same solutions made without the Aβ peptide. After incubation,
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the monolayers were rinsed with the protein-free KOH solution, dried under a stream of N2, and
subsequently evaluated with reflection-absorption infrared spectroscopy and scanning force
microscopy. Two samples were analyzed for each monolayer to verify reproducibility.
2.2.8

Preparation of Beta Amyloid Samples for Analysis of Seeding Effects on Alkanethiol
Monolayers
To analyze the HS-(CH2)11-OH, HS-(CH2)2-(CF2)7-CF3, and HS-(CH2)11-(OCH2CH2)3-

OH monolayers for seeding effects, a separate approach was used. The 100 μM Aβ peptide
solutions in ~10 mM KOH at pH 11.5 were prepared as described above. The high pH inhibits
the aggregation of the protein in solution, so the possibility of surface-induced aggregation can
be evaluated.6, 7 In this scenario, the Aβ peptide solution was incubated on the monolayers for 15
h and 7 days. After the incubation period, the supernatant from the monolayers was removed
and spotted onto a mica substrate to allow for adsorption of any solution-phase protein to the
mica.8 After five minutes, the solution was rinsed away with Nanopure water, and the mica was
then dried under a stream of N2. The resulting sample was analyzed by tapping-mode scanning
force microscopy under ambient conditions. The control sample, which consisted of the Aβ
solution in a polypropylene microcentrifuge tube, was prepared and analyzed the same way.
2.3

Instrumentation and Theory

2.3.1

Reflection-Absorption Infrared Spectroscopy
All reflection-absorption infrared spectroscopy (RAIRS) was performed with a Thermo

Nicolet Nexus FT-IR model 670 ESP with a MCT (mercury-cadmium-telluride) detector. The
instrument was equipped with a Versatile Reflection Attachment with Retro-Mirror Accessory
(Harrick), in order to perform external reflection measurements. RAIRS was carried out using ppolarized light at a grazing incident angle of 86˚ with respect to the surface normal of the sample.
Samples were placed on a highly reflective gold substrate. Spectra were obtained using 512
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scans at a resolution of 4 cm-1. The purge time, to remove possible contamination from water
and carbon dioxide vapor, was approximately 9 minutes. Baseline corrections and subtractions
for water and carbon dioxide were preformed using Omnic ESP Version 5.2a software.
Deconvolution of spectra was performed using GRAMS/32 software that utilizes a Fourier
deconvolution algorithm with a resolution enhancement of 1.4 and a Bessel smoothing factor of
85%. All spectra were placed on a common scale for comparison. Bare gold, prepared by UVozone cleaning immediately before use, under the same experimental setup as the samples, was
used as the reference. The monolayers on Au exposed to both the KOH solution and the Aβ10-35
in KOH were analyzed separately.
2.3.2

Theory of Reflection-Absorption Infrared Spectroscopy
RAIRS, which has become a useful tool for analysis of chemically modified surfaces,9

was first described in 1966 by Greenler, but it was not widely used until the mid-1980s when the
method was combined with commercial FTIR spectrometers.10, 11 Infrared spectroscopy works
by inducing a molecular vibration in a molecule. Energy is absorbed when the frequency of the
radiation matches the frequency of the vibration and the absorb energy results in a peak in the
infrared spectrum.
The instrumental setup for the spectrometer is as follows: an IR source produces an
infrared beam that passes through a Michelson interferometer, which produces an interferogram
that allows multiple vibrational frequencies to be monitored simultaneously. The Michelson
interferometer uses a beamsplitter that divides the infrared beam into two beams. One beam is
reflected off a stationary mirror, while the other beam is reflected off a moving mirror. Both
beams are combined at the beamsplitter. Because one mirror is moving the signal that is
produced when the two beams recombine has a constructive and destructive interference pattern.
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This is called an interferogram and encodes all frequencies into one beam. A HeNe laser is
employed as an internal wavelength calibration standard. The laser is aligned with the IR source
and passes through the interferometer with the IR beam and monitors the position of the moving
mirror. The wavenumber scale of an interferometer originates from this information. After
leaving the interferometer, the IR beam is aimed at a sample on a highly reflective surface. The
IR beam is positioned at a grazing angle to the surface normal where the infrared radiation
interacts with the sample. The resulting signal is then reflected toward a detector where it is
measured. A mathematical Fourier transform is then performed on the signal and an infrared
spectrum is produced. The spectrum of the sample is compared with the peaks corresponding to
the vibrational frequencies of the molecules in the sample to the spectrum of the same system
with no absorption in the thin layer.
The intensity of the infrared radiation reflected from a metal substrate depends upon a
combination of the angle of incidence of the infrared light and the state of polarization of the
light. Incident infrared radiation (the light from the source) combines with the infrared radiation
reflected from the substrate to create a standing wave electric field. The conditions that produce
a standing wave with the highest amplitude are the most desirable.

For light polarized

perpendicular to the plane of incident light (s-polarized) the phase shift remains near to 180° for
all angles of incidence.10 The addition of the incident vector and reflected vector for the spolarized beam cancel each other out almost completely. Thus, the resulting standing wave
electric field has a very low intensity and there should be little absorption of infrared light from a
substrate with reflection of light s-polarized infrared light.

For infrared radiation that is

polarized parallel to the plane of incident light (p-polarized), the phase shift changes rapidly,
especially at angles that are high relative to the normal.10 The incident and reflected standing
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wave vectors at the surface of the substrate are oriented in the same direction and the addition of
the vectors doubles the intensity of the standing wave.

Therefore, the optimal conditions are

that the infrared light should be p-polarized and the incident beam should be oriented at a high
(grazing) angle to the normal of the surface. At the high angle, the intensity of the infrared is
optimized so the sub-micromolar quantities of chemical species can be detected. The resultant
standing wave electric field vector for p-polarized radiation is predominantly perpendicular to
the metal surface, which means that those molecular vibrations whose change in electric dipole is
parallel to the surface will be much less strongly excited.
Another factor affecting the interaction of the IR beam with the sample is the surface
selection rule, which concerns how the molecules must be oriented in relation to the metal
surface. The metal surface contains free electrons. When a molecule is adsorbed on a substrate,
the molecule generates opposite image charges in the electrons in the metal substrate. If the
molecule is oriented parallel to the surface, then the dipole moments of the molecule and the
image charges of the substrate cancel each other out.

When the molecule is adsorbed

perpendicular to the surface, the dipole moment of the molecule and the resulting image charges
of the substrate are oriented in the same direction, which gives rise to a dipole moment twice
what would be expected. Therefore, only the dipole moments oriented perpendicular to the
surface will be observed in the vibrational spectrum.9, 12 Quantification of the amounts of the
various secondary structures on a surface cannot be performed due to the selection rules that
apply for RAIRS.9
Infrared spectroscopy is especially helpful for analyzing proteins because of the
prominence of the amide I bands at roughly 1600 cm–1 due to C=O and C-N stretching and the
amide II bands at roughly 1500 cm–1 that occur because of N-H bending and C-N stretching.13
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The position of these spectral bands also reveals information about the conformation of the
peptide. The characteristic amide I frequencies are due to distinctive electron densities in the
amide C=O groups. These electron densities are produced by the differences in the length and
direction of hydrogen bonds that give rise to differences in the strength of the hydrogen bond for
various conformations of the protein.14 When the amide C=O group is engaged in a strong
hydrogen bond, the electron density in the C=O group will be lower, and an amide I absorption
band will appear lower.14 The strong intramolecular hydrogen bonding that stabilizes the β-sheet
conformation is responsible for the low amide I frequencies for that type of conformation.14 The
β-sheet conformation is also characterized by a split-pattern amide I band composed of a higher
frequency component.

This high frequency component occurs because of the sterically

constrained non-hydrogen-bonded amide C=O groups within β-turns.14

The hydrogen bonds

form between approximately every fourth amino acid in the α-helix conformation, which are
longer and thus weaker than those formed in a normal β-sheet conformation, so the amide I
frequencies will be increased.14 A protein with a random coil conformation has the weakest
hydrogen bonding, so a higher amide I frequency will be present. The positions of peaks for
alpha-helix conformation, random-coil conformation, and beta structures of peptides are
summarized in Table 2.1.15, 16
Table 2.1. Position of IR peaks for secondary protein conformations.
Amide I band position (cm-1)

Beta sheet
conformation
Random coil
conformation
Alpha helix
conformation

Amide II band position (cm-1)

1625-1640, 1665-1695

1530-1535

1650-1655

1545-1550

1645-1650

1548-1553
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2.3.3

Scanning Force Microscopy
A Digital Instruments Nanoscope III scanning probe microscope controller was used to

perform all scanning force microscopy (SFM). A J-type piezoelectric scanner was used that is
capable of acquiring a scan size of up to 125 μm x 125 μm. Noncontact silicon cantilevers [cat #
NSC-15, MicroMasch] were used to obtain the images in tapping mode. These tips had a radius
of curvature of 10 nm and a tip height of 15-20 μm, as stated by the manufacturer. In situ
scanning force microscopy and lateral force microscopy (LFM) employed silicon nitride
cantilevers [cat # NP-S, Veeco]. The silicon nitride tips had a radius of curvature of 10 nm and a
tip height of 2.5-3.5 μm, as stated by the manufacturer.
Samples were attached to magnetic pucks using adhesive. Data for ex situ samples were
taken at room temperature under ambient conditions. In situ experiments were performed under
deionized water (18 MΩ cm) or phosphate buffer solution. Multiple scans from separate areas
were taken for each sample, and the results shown are representative of the entire sample.
After capturing the images, an image flatten method was executed. In the height images
shown, the brightest areas in the image are the tallest features. In the force images, the brightest
areas are the areas that exert the greatest frictional force.
2.3.4

Theory of Scanning Force Microscopy
The scanning force microscope apparatus was developed in 1986 by G. Binnig, C. F.

Quate, and C. Gerber.17-19 The instrument, also known as the atomic force microscope, is
depicted in Figure 2.3. Briefly, the SFM operates by measuring attractive and repulsive forces
between a cantilever tip and a sample.20 The sample is moved under the cantilever tip by a tube
scanner operated by piezoelectric action. As the cantilever moves over the surface, a laser
reflecting off the tip of the cantilever measures the vertical motion of the tip. The reflected laser
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is detected by a photodiode which is divided into four quadrants. The photodiode converts the
signal into topographical information about the sample.
Three types of scanning force microscopy were used: tapping mode SFM, contact mode
SFM, and lateral force SFM, which is a variation of contact mode SFM. Tapping mode SFM
utilizes an oscillating cantilever that taps the sample surface during scanning.

Constant

oscillation amplitude is maintained. As the cantilever comes in contact with the surface, the tip
is deflected, which subsequently shifts the position of the laser beam on the photodiode. The
photodiode translates the reflected laser beam into information regarding the vertical height of
the sample surface.
Split
Photodiode

Mirror

Diode Laser

Cantilever Substrate

Piezoelectric
Tube Scanner

Sample

Figure 2.3 Schematic of Scanning Force Microscope.
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Contact mode SFM operates by observing the change in cantilever deflection when
scanning a cantilever across the sample surface. A constant deflection force is sustained between
the cantilever and the sample by vertically moving the scanner, so that the force between the tip
and sample stays steady. The photodiode determines the vertical distance that the scanner moves
by measuring the difference of the laser position between the top two and bottom two quadrants
of the photodiode.
Lateral force microscopy (LFM) measures the frictional force of the sample and is used
in conjunction with contact mode SFM. As the sample is moved across the cantilever tip, an
additional twisting motion of the cantilever caused by the differences in friction is measured.
This twisting motion also changes the position of the laser on the photodiode between the right
and left quadrants of the photodiode. As the cantilever scans across high-friction areas, the
cantilever is torqued more than when scanning across low-friction areas. The frictional force can
be described by the following equation:
F = α (V – V0)

Equation 2.1

where F is the frictional force, V is the voltage signal due to the deflection in the lateral
direction, V0 is the voltage signal of the undeflected tip with no frictional force, and α
conversion factor which is assumed to be constant.
The interaction of the probe tip and the chemical functionalities in each region of the
patterned monolayer results in different voltage signals. The differences in the voltage signal are
translated into variation in pixel brightness on the image of the surface.

Areas with a higher

friction produce brighter pixels in the LFM image. In the experiments involving the deposition
of Aβ10-35 peptide on patterned alkanethiol monolayers, the probe tip experienced a greater
frictional force in the areas terminated by the ethylene glycol than in the areas covered in the
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unsubstituted alkanethiol monolayer.

This occurred because the ethylene glycol-terminated

monolayer has a higher surface energy than that of the unsubstituted alkanethiol monolayer.21
2.3.5

Fluorescence Photobleaching Recovery Spectroscopy
The Fluorescence Photobleaching Recovery (FPR) apparatus is shown in Figure 2.4.22

The main element of the FPR instrument is an Olympus BH2 epifluorescence microscope with
the illuminator assembly adapted to allow illumination by a light source. A Lexel EXCEL 3000
argon ion laser capable of producing 2 W at 488 nm is used. The laser beam is passed through
an acoustooptic modulator (AOM) [cat # 35085, Newport Research] driven by a modified radiofrequency source [cat # 31085-6DS, Newport Research]. The first-order diffracted beam, about
85% of the laser output, is used for photobleaching. A movable coarse diffraction grating (50,
100, 150, and 300 lines/inch), referred to as a Ronchi ruling, located at the rear focal plane of the

Photomultiplier
Tube
Shutter

Ronchi
Ruling

Mirror

Dichroic
Mirror
Objective

Mirror
ARGON ION LASER
Acoustooptic
Modulator

Figure 2.4 Schematic of Fluorescence Photobleaching Recovery Spectroscopy Apparatus.
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microscope objective is used to produce a striped pattern in the beam. The patterned beam is
deflected by a dichroic mirror and focused by the microscope objective (4X, 7X, 10X, and 18X)
onto the stage, where it can bleach a fluorescently labeled sample. A photomultiplier tube
(PMT) [cat # 7265, RCA] receives the fluorescence emitted from the sample. An 846HP shutter
[cat # 846HP, Newport Research] remains closed during the photobleaching pulse to protect the
PMT. The PMT produces an intensity readout that is sent to a computer where it is translated
into information regarding the diffusion of the sample.
2.3.6 Theory of Fluorescence Photobleaching Recovery Spectroscopy
Fluorescence photobleaching recovery is a beneficial technique that can be used to
determine the physical characteristics of large molecules from their diffusion properties. In
brief, a laser is used to print a pattern onto a fluorescently labeled sample. The pattern begins to
fade and the fluorescence recovery is monitored as the bleached molecules diffuse into the
unbleached areas of the sample. The FPR apparatus is arranged such that either a spot or a
fringed pattern is bleached onto a sample. In the following experiments, a fringed pattern is
used. The fringe pattern is acquired by using a Ronchi ruling located at the rear focal plane of
the microscope objective lens. First, the Ronchi ruling is used as a photomask and the sample is
bleached with a laser. After bleaching with a laser, a striped image replicating the fringed
pattern of the Ronchi ruling is imprinted in the sample. The period of the striped pattern on the
sample is related to the Ronchi ruling constant, K=2π/L, where L is the period of the repeat
pattern in the sample. During the fluorescence recovery phase, the Ronchi ruling is shifted at a
constant rate through the laser. This results in a period component in the fluorescence emission
of the sample as the periodic light field falls into and out of phase with the pattern that was
bleached into the sample.23 Fluorescence recovery is measured as a function of ac voltage,
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which corresponds to the contrast of the pattern. The ac voltage decays exponentially at a rate
proportional to the diffusion coefficient:
ac volts = exp (-Γt)

Equation 2.2

where t is the time since the photobleach, Γ=DK2 where D is the tracer self-diffusion coefficient,
and K is the grating constant, K=2π/L, where L is the period of the repeat pattern. The diffusion
coefficient is obtained from the slope of Γ versus K2 plot. Size information can also be obtained
via the Stokes-Einstein equation:
Ds=kBT/(6πηRh)

Equation 2.3

B

Where kB is the Boltzmann constant, η is the solvent viscosity Rh is the hydrodynamic radius.
The shape of the molecule is assumed to be spherical.

2.4
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Chapter 3
Surface-Induced Aggregation of Beta Amyloid Peptide *

3.1

Introduction
Soluble beta amyloid (Aβ) protein is normally found in the human brain, but due to

unknown causes, the Aβ peptide folds into β-sheet structures in the brain which, in turn, lead to
the formation of insoluble aggregates and fibrils.1,
cells.3,

4

2

These aggregates are toxic to neuronal

There is evidence that Aβ fibril assembly is effected by interactions with biological

surfaces, such as membranes,5-12 therefore we propose that the physiological environment of the
Aβ peptide may contribute to the formation of the amyloid plaques that are present in the brains
of Alzheimer’s patients.
The goal of the work described here is a better understanding of the effects of surface
chemistry on the aggregation of Aβ peptide.

Surfaces composed of self-assembled, ω-

substituted alkanethiol monolayers on Au were used to investigate their influence on the
aggregation of Aβ peptide. Several different ω-substituted alkanethiol monolayers on Au were
used, such as those terminated with methyl (HS-(CH2)17-CH3), alcohol (HS-(CH2)11-OH),
carboxylic acid (HS-(CH2)15-COOH), fluoro-methyl (HS-(CH2)2-(CF2)7-CF3), sulfonic acid (HS(CH2)10-SO3H), and ethylene glycol (HS-(CH2)11-(OCH2CH2)3-OH) functionalities.

These

model surfaces were used to determine the effect of surface chemistry on the deposition and
aggregation of Aβ peptide.
Reflection-absorption infrared spectroscopy (RAIRS) and scanning force microscopy
(SFM) were chosen to evaluate the conformation and topography of Aβ structures on the

*
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monolayers. Infrared spectroscopy is a powerful tool for analyzing the conformation of proteins
because the positions of the amide I and amide II bands are indicative of the environment of the
amide carboxyl and N-H moieties.13 Scanning force microscopy allows for high-resolution
imaging of the aggregation behavior of the Aβ protein on the monolayers, specifically the type
and size of aggregates.
3.2

Surface-Induced Beta Amyloid Peptide Aggregation – Reflection-Absorption
Infrared Spectroscopy Studies
To evaluate the ability of the monolayers to induce aggregation only on their surfaces, Aβ

solutions with a high pH were used. The high pH inhibits the aggregation of Aβ peptide in
solution so that the possible effects of the surface on aggregation can be evaluated.14, 15 From
RAIRS data of various alkanethiol monolayers on Au exposed to N2-purged KOH solutions for
times up to 40 days (with no protein present), there is no indication of any changes in monolayer
structure.
RAIRS is a potent methodology for determining the secondary structural nature of
proteins in various environments. The structure of proteins can be correlated with the positions
of the amide I (C=O stretch, 1600-1700 cm-1) and the amide II (C-N stretch and N-H
deformation, 1530-1560 cm-1) band frequencies.16-18 The β-sheet conformations are uniquely
distinguished by a split-pattern amide I band composed of a lower frequency component, 16251640 cm-1, and a less intense, higher frequency component at 1685-1695 cm-1. In addition, the βsheet conformation exhibits an amide II transition between 1530 and 1535 cm-1.

Another

component of β-structure, namely β-turns, possess bands in the amide I region that are located
between 1660 and 1680 cm-1; the bands in the amide II region overlap with those of the β-sheet
structure. It is common for β-structures to have more that one band present in each region.19
Random coil conformations are characterized by an amide I band in the 1650-1655 cm-1 region
40

and an amide II band in the 1545-1550 cm-1 region. α-Helical conformations result in amide I
transitions centered near 1645-1650 cm-1, as well as an amide II band between 1548 and 1553
cm-1. Low frequency amide I bands in the 1600-1625 cm-1 region can be attributed to side chain
vibrations of the protein.20
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HS-(CH2)17-CH3
HS-(CH2)15-COOH

Absorbance

HS-(CH2)2-(CF2)7-CF3
HS-(CH2)10-SO3H

HS-(CH2)11-OH
HS-(CH2)11-(OCH2CH2)3-OH

4000

3000

2000

1000
-1

Wavenumber (cm )

Figure 3.1. Reflection-absorption infrared spectra of T-substituted alkanethiol monolayers
on Au exposed to aqueous solutions of 100 μM Aβ10-35 in 10 mM KOH (pH 11.5) for 15 h.
RAIRS experiments clearly indicate that all of the monolayers on Au investigated here,
except the HS-(CH2)11-(OCH2CH2)3-OH monolayer, cause deposition of the Aβ peptide, as
evidenced by observation of amide I and amide II bands for the surfaces studied within a 15-h
incubation period.

Results are displayed on a common scale in Figure 3.1 for the 15-h

incubation period. Curve fitting band deconvolution was performed on each spectrum to resolve
the overlapped peaks that sometimes occur when two protein conformations are present.21 These
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results are displayed in Tables 3.1 and 3.2, with the reported values being for the center of each
band. Curve fitted spectra are provided in Appendix A. Spectra of the various thiol monolayers
on Au exposed to the KOH solutions for a 15-h incubation period (with no protein present) are
provided in Appendix A.
Examination of the spectrum for the methyl-terminated monolayer exposed to Aβ
solutions for 15 h revealed bands in the amide I and amide II regions that are attributed to the
adsorption, not absorption, of Aβ peptide. Because no observable change in the peak maxima
positions for the symmetric (νS, CH) and asymmetric (νA, CH) C-H stretches of the alkane
moiety of the monolayer were noted, it appears that no absorption of the peptide occurred. If the
protein were to penetrate the alkanethiol chains (absorption), disordering of the monolayer
chains would be expected, leading to changes in the band positions of νS (CH) and νA (CH).22 It
is concluded that adsorption is the most significant route in the deposition of Aβ on the
monolayer-modified surfaces.
Amide I bands resolved by deconvolution of the original spectra were centered at 1632
cm-1, 1695 cm-1, and 1681 cm-1 (Table 3.1), which indicate a β-sheet conformation; at 1666 cm-1,
which indicates a β-turn conformation; and at 1649 cm-1, which indicates an α-helix
conformation. The presence of both β-structures and α -helix conformations is supported by the
position of the amide II bands at 1536 cm-1 and 1553 cm-1 (Table 3.2) for the protein deposits.
Quantification of the amounts of the various secondary structures cannot be performed due to the
selection rules that apply for RAIRS.23
Based on similar evaluations of the spectra, it is found that the sulfonic acid-, carboxylic
acid-, alcohol-, and trifluoromethyl-terminated monolayers all cause adsorption/deposition of Aβ
peptide on their surfaces. In addition, all of these surfaces are covered with protein possessing β-
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sheet and β-turn, random coil, and α -helical conformations. It is important to note that the
ethylene glycol-terminated monolayers24, 25 do not exhibit IR spectra characteristic of Aβ peptide
adsorption, for times up to 40 days, which was the limit of our study.
Table 3.1. Amide I band positions for the deconvoluted RAIR spectra of monolayers
exposed to 100 μM Aβ10-35 in 10 mM KOH (pH 11.5) for 15 h.

Monolayer system
HS-(CH2)17-CH3
HS-(CH2)11-OH
HS-(CH2)2-(CF2)7-CF3
HS-(CH2)15-COOH
HS-(CH2)10-SO3H

Band positions for deconvoluted amide I transitions
in Figure 3.1 (cm-1)
β-sheet
β-turn
Random
α-helix
Side chain
coil
1632, 1695,
1666
1649
1616,
1681
1603
1636, 1687
1665
1615,
1601
1634, 1698,
1682, 1674,
1618,
1690
1660
1607
1632, 1693
1673
1648
1638, 1689,
1678, 1669
1655
1617,
1681
1603

Table 3.2. Amide II band positions for the deconvoluted RAIR spectra of monolayers
exposed to 100 μM Aβ10-35 in 10 mM KOH (pH 11.5) for 15 h.

Monolayer system
HS-(CH2)17-CH3
HS-(CH2)11-OH
HS-(CH2)2-(CF2)7-CF3
HS-(CH2)15-COOH
HS-(CH2)10-SO3H

Band position for deconvoluted amide II transitions in
Figure 3.1 (cm-1)
β-structures
Random coil
α-helix
1536
1553
1539
1539
1537
1549
1534
-

Further analysis of the fluorinated monolayer with longer incubation times revealed that
the protein conformations present changed slightly over a period of 20 days (Figure 3.2), with a
minor shift from β-structure towards α-helical conformations. Curve fitting band deconvolution
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was performed on each spectrum in Figure 3.2 to resolve overlapped peaks. These results are
displayed in Table 3.3, with the values shown being for the center of each band. Curve fitted
spectra are provided in Appendix 1.
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Figure 3.2. Reflection-absorption infrared spectra of CF3-(CF2)7-(CH2)2-SH/Au exposed to
aqueous solutions of 100 μM Aβ10-35 in 10 mM KOH (pH 11.5) for 15 h, 7 days, and 20
days.
Table 3.3. Band positions for the deconvoluted RAIRS spectra of CF3-(CF2)7-(CH2)2SH/Au exposed to 100 μM Aβ10-35 in 10 mM KOH (pH 11.5) for 15 h, 7 days, 20 days.

Exposure
time
15 h
7 days
20 days

Band positions for deconvoluted amide I
transitions in Figure 3.2
β-sheet
β-turn
Random
αcoil
helix
1634,
1682,
1698, 1690 1674, 1660
1637,
1670
1654
1689, 1681
1633, 1680
1662
1644
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Band positions for deconvoluted
amide II transitions in Figure 3.2
βRandom
α-helix
structure
coil
1539
1538

-

1547

1534

1550

-

The position of the amide I bands remained stable for the fluorinated monolayer,
indicating the presence of β-structures for incubation times of 15 h, 7 days, and 20 days.
Additionally, the Aβ peptide incubated on the fluorinated monolayer for 7 days had a random
coil conformation indicated by the band centered at 1654 cm-1. The Aβ peptide incubated on the
fluorinated monolayer for 20 days had an α-helix conformation in addition to the β-structure
conformation.

Intramolecular hydrogen bonding can explain the presence of the α-helix

conformation. Intramolecular hydrogen bonding is promoted after a protein is adsorbed onto a
hydrophobic surface because it is unlikely that the protein will form hydrogen bonds with the
monolayer since the monolayer is terminated with fluorocarbon endgroups.26 When compared
on a common scale, the intensities of the amide I and amide II bands increased over time, an
observation that indicates that the monolayer had more Aβ peptide deposited on it as time
progressed. Since the dipole moment of the C=O group (amide I band) is oriented orthogonally
to that of the C-N group (amide II band) on the protein and both band intensities increase, it can
be concluded that this increase is due to a growth in the amount of peptide on the surface and not
just a change in orientation.
3.3

Surface-Induced Beta Amyloid Peptide Aggregation – Scanning Force Microscopy
Studies
The fluorinated monolayer was chosen for in-depth SFM studies due to the observation in

the RAIRS studies that the CF3-layer accumulated more Aβ than the other surfaces as a function
of time. SFM inspection of the fluorinated monolayer was made at 15 h, 7 days, and 20 days of
exposure to the Aβ solution; the results are displayed in Figure 3.3. In Figure 3.3A is shown the
SFM image of the CF3 monolayer on Au exposed to KOH for 15 h demonstrating the absence of
any topographical features other that those associated with the monolayer-covered Au surface.
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A.

B.

C.

D.

Figure 3.3. 2 μm x 2 μm tapping mode scanning force micrographs of CF3-(CF2)7-(CH2)2SH/Au exposed to: A. 10 mM KOH for 20 days; B. 100 μM Aβ10-35 (in 10 mM KOH, pH
11.5) for 15 h, C. 7 days, and D. 20 days. Z-range=50 nm in A-D.
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After 15 h of exposure to the Aβ solution, rod-like aggregates approximately 150 nm in
length and 25 nm in height had formed (Figure 3.3B) on the fluorinated monolayer. By 7 days of
exposure, the aggregates of Aβ peptide were observed to be roughly 300 nm in length and 50 nm
in height (Figure 3.3C). Aggregation length and height for the largest particles had reached 450
nm and 50 nm by day 20 (Figure 3.3D). The length of individual aggregates was judged to be
their greatest lateral dimension. SFM can be used to give only partial information about the
length of the aggregates because tip-sample convolution can limit resolution.27
The SFM results are in agreement with the findings of the time-dependent RAIRS work.
Both studies indicate that the Aβ peptide continues to deposit on the monolayer with time, and
the RAIRS data allow it to be concluded that the types of peptide conformations present do not
change significantly with increased exposure time. SFM confirms that more Aβ peptide is
adsorbed to the surface of the monolayer as exposure time is increased.
3.4

Seeding Effects of the Monolayers
An additional question to be addressed is whether Aβ aggregates that are adsorbed to the

monolayer surfaces dissociate from the monolayer and enter solution. If the aggregates do
dissociate from the monolayers, it is expected that they would act as seeds for initiating
aggregation of Aβ protein in the solution.28 A comparison between the supernatant from the
fluorinated, alcohol, and ethylene glycol monolayers and a control, which consisted of the Aβ
solution in a polypropylene microcentrifuge tube, was conducted using scanning force
microscopy. A high-pH solution was used to retard aggregates from forming. Multiple SFM
scans from various areas on the samples were performed, and the results shown are
representative of the entire sample surfaces.
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The results from the control, which consisted of Aβ peptide solution from a
polypropylene vial that was subsequently spotted onto mica for analysis, are displayed in Figure
3.4A-B. After a 15-h incubation period, the solution had formed very few aggregates, Figure
3.4A. The aggregates that had formed were approximately 40 nm in length and 25 nm in height.
Following an incubation of 7 days, the aggregates were larger, with lengths ranging from 75 to
100 nm and heights of approximately 40 nm, Figure 3.4B.
B.

A.

Figure 3.4. 10 μm x 10 μm tapping mode scanning force micrographs of 100 μM Aβ10-35
peptide in 10 mM KOH solution at pH 11.5 from a vial incubated at room temperature for
A. 15 h and B. 7 days. For experiments, 50 μL of solution was spotted on mica, allowed to
sit for 5 minutes, and then the resulting surface was rinsed with 18 MΩ-cm water and
dried. Z-range=50 nm.
After a 15-h incubation of the Aβ solution with the CF3 monolayer, the Aβ protein had
formed many aggregates in solution approximately 40 nm in length and 25 nm in height.
Following a 7-day incubation with the CF3-layer, the Aβ aggregates were larger, with lengths
ranging from 75 to 100 nm and heights of approximately 40 nm, Figure 3.5A.
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In order to probe the effects of the monolayer on the production of the Aβ aggregates in
solution, a study involving the alcohol monolayer was pursued. After a 15-h incubation of the
Au-supported, alcohol-terminated alkanethiol with the Aβ solution, protein aggregates
approximately 60 nm in length and 25 nm in height were observed (data not shown). After 7
days of incubation, the Aβ protein had formed larger aggregates approximately 50 nm in height
and 100 to 135 nm in length (Figure 3.5B).
B.

A.

Figure 3.5. 10 μm x 10 μm tapping mode scanning force micrographs of 100 μM Aβ10-35
peptide in 10 mM KOH solution at pH 11.5 from various experiments. A. Supernatant
from the CF3-(CF2)7-(CH2)2-SH/Au monolayer exposed to 100 μM Aβ10-35 peptide in 10
mM KOH for 7 days. B. Supernatant from the HO-(CH2)11-SH/Au monolayer exposed to
100 μM Aβ10-35 peptide in 10 mM KOH for 7 days. For experiments, 50 μL of supernatant
was spotted on mica, allowed to sit for 5 minutes, and then the resulting surface was rinsed
with 18 MΩ-cm water and dried. Z-range=50 nm.
After analysis of the Aβ solutions, it is clear that the Aβ solution from the polypropylene
vial, which was the control, exhibited very little protein aggregation. The Aβ solution from the
fluorinated monolayer experiment had a much greater extent of peptide aggregation than the
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control, while the alcohol monolayer had the most aggregation of Aβ protein, as judged by
aggregation length and number. In comparison, the Aβ protein solution taken from the ethylene
glycol-terminated monolayer exhibited very little protein aggregation (Figure 3.6A), which was
comparable to the control from the vial. The ethylene glycol-terminated monolayer did not
adsorb the Aβ protein (Figure 3.6B), which accounts for the fact that there was very little protein
A.

B.

Figure 3.6. 10 μm x 10 μm tapping mode scanning force micrographs of 100 μM Aβ10-35
peptide in 10 mM KOH solution at pH 11.5. A. Supernatant from the HS-(CH2)11(OCH2CH2)3-OH /Au monolayer exposed to 100 μM Aβ10-35 peptide in 10 mM KOH for 40
days. B. HS-(CH2)11-(OCH2CH2)3-OH / Au monolayer exposed to 100 μM Aβ10-35 peptide
in 10 mM KOH for 40 days. For the supernatant experiments, 50 μL of supernatant was
spotted on mica, allowed to sit for 5 minutes, and then the resulting surface was rinsed with
18 MΩ-cm water and dried. Z-range=50 nm.
aggregation in solution. If the protein does not adsorb to the monolayer surface, there is not a
nucleus present for seeding polymerization to begin.

These results indicate that the Aβ

aggregates do dissociate from the monolayers after their formation. However, in consideration
of the SFM images of the exposed monolayer surfaces themselves (not shown) and of the RAIRS
data (vide supra), it was evident that the fluorinated monolayer possessed more protein deposits
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than did the alcohol monolayer. Therefore, for the fluorinated monolayer, there would be less
protein available in solution from which aggregates would form.
Amyloid solutions before and after incubation with the alcohol- and fluoromethylterminated monolayers were evaluated to determine the peptide content (amino acid analysis) of
the solution after incubation. Results confirmed the initial hypothesis regarding the difference
between the adsorption propensities of the different monolayers, that is, the CF3 monolayer had
removed more Aβ peptide from the solution than had the alcohol-terminated monolayer. Amino
acid analysis of the solutions after incubation revealed that the peptide content of the solution
from the fluorinated monolayer was less than that of the alcohol monolayer by a factor of 10.
Therefore, the reason the alcohol monolayer had more of a seeding effect was because there was
more peptide in the solution for aggregates to form from the displaced seeds. In addition, by
comparing the solutions from the monolayers with the solution from the polypropylene vial and
the ethylene glycol-terminated monolayers on Au (controls), it can be concluded that the
monolayers do induce aggregation of the Aβ peptide in solution, because the controls does not
have the extent of aggregation that the solution from the monolayers have.
In Figure 3.7 is depicted a proposed model describing the interaction of the Aβ peptide
with the monolayer surfaces. Initially, the Aβ peptide is adsorbed onto the monolayer surface (A
to B), where it subsequently undergoes a change in conformation to a β-sheet (B to C). At this
stage, the process can then follow two pathways. In one path (C to D), the surface accrues more
peptide due in part to the confined β-sheet form acting as a template to yield larger surfaceconfined aggregates. In the second path (C to E), the β-sheet form of the peptide on the
monolayer is moved to solution wherein the folded peptide (monomer or higher-order
aggregates) interacts with monomeric Aβ peptide to form larger aggregates (E to F). These
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larger, solution-phase aggregates can either continue to grow upon interaction with monomeric
peptide or be deposited back onto the surface of the monolayer (F to D).
Protein

Protein
Adsorption/Deposition

Monolayer

B.

A.

Conformation
Change on Surface

Folded Protein

C.
Dislodged Folded Protein
Acts as Template in Solution

Protein
Adsorption/Deposition
and Deposit Growth

E.
D.
Protein Aggregate
Seeding

Protein-Aggregate
Adsorption/Deposition

F.

Figure 3.7. Model of the surface interaction and subsequent aggregation of Aβ10-35 peptide
exposed to various ω-substituted alkanethiol monolayers.
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The surface-induced aggregation of Aβ peptide as a route to the formation of solutionphase aggregates and surface-bound aggregates is an important issue in understanding the
mechanism of action of Aβ peptide aggregates and their role in Alzheimer’s disease.6,

12

Although the impact of surface charge of lipid bilayer vesicles on the interaction of Aβ peptide
with such lipid membranes has been demonstrated,6-9 little information exists surrounding the
relationship between the deposition, folding and aggregation of solution-phase Aβ peptides and
the chemical nature of non-ionic surfaces. The work described here is a first attempt at relating
the chemical makeup of supported, model monolayer surfaces and their propensity to interact
with Aβ peptide in solution. The outcomes are important, for it is clear that the relatively “nonspecific” interactions of Aβ peptides with certain surfaces may be similar to that observed for
ganglioside-terminated lipid vesicles, the latter which have been shown to cause formation of Aβ
peptide β-sheets.29
3.5

Conclusions
Reflection-absorption infrared spectroscopy analysis revealed that deposition of Aβ10-35

occurred onto both hydrophilic and hydrophobic surfaces under conditions that do not lead to
aggregation in solution. In addition, the RAIRS studies demonstrated that the conformation of
the adsorbed Aβ10-35 does not change over a period of 40 days of exposure, and the amount of Aβ
deposited increases with exposure time. Scanning force microscopy confirmed that the amount
of aggregated deposits increased with exposure time.

Studies of the solutions exposed to

monolayers revealed that the monolayers have a seeding effect on Aβ peptide in solution, leading
to the conclusion that monolayers actually induce aggregation of Aβ peptide in solution.
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Chapter 4
Effect of Patterned Monolayers with Different Chemical Functionalities on the SurfaceInduced Aggregation of the Beta Amyloid Peptide
4.1

Introduction
It has been found that Au surfaces consisting of self-assembled monolayers (SAMs)

terminated with methyl (HS-(CH2)17-CH3), alcohol (HS-(CH2)11-OH), carboxylic acid (HS(CH2)15-COOH), fluoro-methyl (HS-(CH2)2-(CF2)7-CF3), sulfonic acid (HS-(CH2)10-SO3H)
chemical functionalities, adsorbed Aβ protein (fouling) and could induce the aggregation of Aβ
protein in solution, and that SAM surfaces terminated with ethylene glycol (HS-(CH2)11(OCH2CH2)3-OH) chemical functionalities did not adsorb Aβ protein (non-fouling) or cause
aggregation of the Aβ protein in solution. The next step in this series of experiments was to form
patterned surfaces consisting of monolayers with fouling and non-fouling surface properties to
determine if areas of fouling monolayers embedded in non-fouling monolayers affected the
deposition of the Aβ protein on both of these surfaces or the aggregation of the Aβ protein in
solution. This system was used to model a cell membrane that has a particular type of isolated
chemical functionality which could act as a nucleation site for inducing aggregation of Aβ
protein on a surface that would not usually affect the Aβ protein. This is an important model
because it has been shown that Aβ protein will bind to gangliosides implanted in lipid vesicles,
and this immobilized protein can act as a nucleation seed to form the Aβ protein aggregates.1-3
The formation of aggregated Aβ protein from soluble Aβ protein by seeded polymerization is
regarded as a crucial step in the progress of Alzheimer’s disease.4
Microcontact printing was chosen to construct the patterned monolayer surfaces. This
technique is generally used to control topographical features and spatial presentation of surface
molecules. Microcontact printing has become a useful tool in the manufacture of microanalytical
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devices, such as chemical and biological sensing devices.

Patterned monolayers are also

commonly used as model system for studying protein deposition at interfaces.5-8
Ethylene glycol functionalities are commonly used as a surface coating to prevent nonspecific protein deposition. Several literature studies have revealed that an ethylene glycolterminated SAM, HS(CH2)11(OCH2CH2)3OH on Au, is resistant to protein deposition.9-11
Preliminary reflection-absorption infrared spectroscopy (RAIRS) and scanning force microscopy
(SFM) studies showed that the ethylene glycol-terminated SAM was non-fouling for the Aβ
protein for up to a forty-day incubation period (Figures 3.1 and 3.6). Therefore, it appeared that
this SAM was suitable to be used as a non-fouling model surface in the Aβ protein on patterned
monolayer experiments. The methyl-terminated alkanethiol monolayer, HS(CH2)17CH3 on Au,
was shown to adsorb the Aβ protein in the previous studies (Figure 3.1), so it was a suitable
coating to be used for the fouling areas in the patterned monolayer surfaces. The methylterminated alkanethiol was chosen over the other fouling alkanethiol monolayers because it
resists degradation and has a chemical composition similar to cell membranes.5, 12-15
4.2

Motivation
The aim of this project was to use a patterned monolayer surface constructed via

microcontact printing of a fouling SAM, HS(CH2)17CH3 on Au, surrounded by a non-fouling
SAM, HS(CH2)11(OCH2CH2)3OH on Au, to determine the effect that the small, fouling areas
have on the deposition and aggregation of the protein in the presence of a non-fouling
monolayer. This experiment was used to gain a better understanding of how surfaces,
specifically the combination of fouling and non-fouling areas on the same surface, influence the
aggregation of Aβ peptide. SFM and lateral force microscopy (LFM) were used to detect and
monitor the protein on the patterned surfaces. Because of the tribological variances of the two
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types of monolayers, LFM was used to distinguish between different types of chemical
functionalities present in the pattern. Height-mode SFM was used to determine where the Aβ
protein had adsorbed to the monolayer surface.
There are several questions to be answered by this experiment. It will be informative to
observe how the combination of fouling and non-fouling areas affects the adsorptive properties
of each other. It could be determined whether the protein will still adhere to the fouling
monolayer in the presence of a non-fouling monolayer, and if the non-fouling monolayer resists
all protein deposition in the presence of a fouling surface. If the protein does adsorb onto the
fouling monolayer, it could further be determined if the protein remains confined to that fouling
monolayer. It is possible that the seeding effect of the fouling monolayer has the capacity to
cause the protein to grow onto the non-fouling surface, which could possibly give insight to how
Aβ plaques form in the brain. Previous studies indicate that the protein can absorb on a fouling
monolayer, form larger aggregates and then desorb from the surface into solution where it acts as
a nucleus for further aggregation in solution, which is called the seeding effect of the surface.
In the previous studies analyzing the seeding effect of the monolayers, the alkanethiol
monolayer induced aggregation of the protein in solution, while the ethylene glycol-terminated
monolayer seemed to prevent aggregation of the protein in solution. Therefore, the effect of the
combination of the surface fouling and non-fouling moieties on the aggregation of the protein in
solution will also be determined. If the protein does desorb from the surface, it will also be
verified what happens to the protein after desorption. It is also possible that the aggregated
protein could desorb from the fouling surface and drop back down on the non-fouling surface. It
will be determined if the protein would settle on the non-fouling surface and continue to
aggregate on that surface.
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4.3

Experimental
The patterning of the monolayer was constructed via microcontact printing.16

Poly(dimethyl siloxane), PDMS, stamps with different size patterns were used. Two different
sizes of patterns were used to determine if the dimensions of the fouling and non-fouling areas
affected the deposition of the aggregates of Aβ protein to the surfaces. Methyl-terminated
alkanethiol, HS(CH2)17CH3, in ethanol was applied to the stamp and allowed to absorb for 30
seconds. The stamp was then dried with N2 and immediately applied to a freshly cleaned Au
substrate. After three minutes, the stamp was removed from the Au, and the Au/patterned
methyl-terminated alkanethiol monolayer was placed in an ethylene glycol-terminated
alkanethiol solution, HS(CH2)11(OCH2CH2)3OH, in ethanol. The ethylene glycol-terminated
alkanethiol then self-assembled in the bare areas to completely fill in the pattern. A patterned
monolayer is shown in Figure 4.1. The height image (left side) was relatively smooth displaying
the Au (111) crystallite features associated with the monolayer-covered Au surface while the
friction image (right side) exhibited the differences in the surface energy of the separate chemical
functionalities. The light color in the Z-range friction scale of the LFM images represents a
higher surface friction. Therefore, in this and all of the following figures, the ethylene glycolterminated monolayer correlate to the lighter areas of the LFM images, while the methylterminated alkanethiol monolayer were the darker areas of the LFM images.
After the patterned monolayers were formed, they were incubated with Aβ protein for
various amounts of time. Analysis was done using in situ SFM while incubating the Aβ protein
with the patterned monolayer so that the formation of the Aβ aggregates could be analyzed in
real time. Analysis was done using SFM and LFM to simultaneously measure the height and
friction of the samples.
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HS(CH2)11(OCH2CH2)3OH

HS(CH2)17CH3

Figure 4.1. 5.4 μm x 5.4 μm contact mode scanning force micrographs of a patterned
monolayer on Au. The height image is on the left and the friction image is on the right. In
the friction image the HS(CH2)11(OCH2CH2)3OH monolayer is evidenced by the lighter
areas. The Z-range is 10 nm for the height image and is 0.5 V for the friction image.

4.4

Deposition of Beta Amyloid on a Small-Scale Patterned Monolayer
In situ SFM was performed to monitor possible deposition and aggregation of Aβ protein

on the patterned monolayer. A small scale patterned was originally chosen. The stamp consisted
of small areas with repeat pattern widths of 1 μm. Approximately 15% of the resulting patterned
monolayer consisted of the fouling HS(CH2)17CH3 monolayer. Initial analysis was done with a
patterned monolayer that had been exposed to 100 μM beta amyloid in 10 mM KOH solution at
pH 11 for 15 hours (Figure 4.2). The spacing of the line pattern was approximately one
micrometer apart. The height SFM image is located on the left, while the right side contains the
frictional LFM image. The brighter color in the Z-range scale of the LFM images represents a
higher surface friction.

Therefore, in Figures 4.2 and 4.3, the ethylene glycol-terminated

monolayer are depicted by the lighter areas of the LFM image, while the alkanethiol monolayer
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are the darker areas of the LFM image. This difference in friction occurred because the ethylene
glycol functionality had a higher surface energy than the unsubstituted alkanethiol
functionality.17 When the Aβ protein was incubated on a small-scale pattern of the fouling and
non-fouling monolayers, it appeared that the Aβ protein adsorbed onto the ethylene glycol
domains even though the ethylene glycol-terminated monolayers were supposed to be nonfouling. After the Aβ protein had been incubated on the patterned monolayer for 40 hours, the
Aβ protein spread significantly onto the ethylene glycol-terminated portion of the monolayer
(Figure 4.3). The aggregates were approximately 100 nm in length and 25 nm in height. This
was unexpected because previous studies (Chapter 3) showed that the ethylene glycol-terminated

HS(CH2)11(OCH2CH2)3OH

HS(CH2)17CH3

Figure 4.2. 5 μm x 5 μm in situ contact mode scanning force micrographs of a patterned
monolayer exposed to 100 μM beta amyloid in 10 mM KOH solution at pH 11 for 15 hours.
The height image is on the left and the friction image is on the right. In the friction image
the HS(CH2)11(OCH2CH2)3OH monolayer is shown in the lighter areas. The Z-range is 50
nm for the height image and 0.1 V for the friction image.
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HS(CH2)11(OCH2CH2)3OH

HS(CH2)17CH3

Figure 4.3. 5 μm x 5 μm in situ contact mode scanning force micrographs of a patterned
monolayer exposed to 100 μM beta amyloid in 10 mM KOH solution at pH 11 for 40 hours.
The height image is on the left and the friction image is on the right. In the friction image
the HS(CH2)11(OCH2CH2)3OH monolayer is shown in the lighter areas. The Z-range is 50
nm for the height image and 0.1 V for the friction image.
monolayer exhibited negligible Aβ protein deposition. In this case, boundary failure of the
patterned monolayer was found, which is defined as the invasion of the protein onto the nonfouling regions. The adsorptive properties of the methyl-terminated monolayer appear to be
stronger than the protein-resistant characteristics of the ethylene glycol-terminated monolayer
because the Aβ protein was present on the ethylene glycol-terminated portion of the monolayer.
In this situation, it appears that the Aβ protein did not grow onto the non-fouling monolayer from
the fouling monolayers, but rather nucleated and aggregated on the fouling monolayer, then
desorbed from the fouling monolayer and readsorbed on the non-fouling monolayer surface. The
spacing of the two monolayers could be too close together allowing for mixing of the
monolayers to occur since the monolayers are slightly fluid.17, 18 If the monolayers are mixed,
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the Aβ protein would adsorb onto the few HS(CH2)17CH3 chains present in the
HS(CH2)11(OCH2CH2)3OH areas.
4.5

Deposition of Beta Amyloid on a Large-Scale Patterned Monolayer
A larger-scale pattern was chosen next to determine if the closeness of the two

monolayers could be the reason the Aβ protein was able to adsorb onto the ethylene glycol
monolayers. The PDMS stamp used in these studies was constructed using a semiconductor
wafer as a negative relief pattern. This stamp provided a variety of patterns on the same stamp
with repeat pattern widths ranging from 10 μm to 20 μm. Approximately 12% of the resulting
patterned monolayer consisted of the fouling HS(CH2)17CH3 monolayer.

HS(CH2)11(OCH2CH2)3OH
HS(CH2)17CH3

Figure 4.4. 50 μm x 50 μm scanning force micrographs of a patterned monolayer exposed
to 100 μM beta amyloid in 10 mM KOH solution at pH 11 for 12 hours. The height image is
on the left and the friction image is on the right. In the friction image the
HS(CH2)11(OCH2CH2)3OH monolayer is shown in the lighter areas. The Z-range is 100
nm for the height image and 1.0 V for the friction image.
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HS(CH2)17CH3

Figure 4.5. 12 μm x 12 μm scanning force micrograph height image of a patterned
monolayer exposed to 100 μM beta amyloid in 10 mM KOH solution at pH 11 for 12 hours.
Z-range is 50 nm.

The patterned monolayers were analyzed with ex situ SFM at 12- and 48-hour intervals.
After a 12-hour incubation period (Figure 4.4), the Aβ protein had begun to adsorb onto the
alkanethiol-terminated monolayer. Although the majority of the ethylene glycol-terminated
monolayer remained protein free, several large Aβ protein aggregates (~500 nm) were present on
the ethylene glycol-terminated monolayer. When examining a close up height image, the edges
of the pattern were sharply defined, as shown in Figure 4.5, indicating that the Aβ protein was
mainly confined to the methyl-terminated monolayer. At this point in time, the adsorptive
properties for the two monolayers were what would be expected.
After the Aβ protein was exposed to the patterned monolayer for 48 hours, the protein
had completely covered the methyl-terminated monolayer (Figure 4.6). There were some large
structures present on the surface that are attributed to defects in the gold. The interface between
the two monolayers was still clearly defined, but there was visible protein deposition on the
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ethylene glycol-terminated monolayer.

Once again, when comparing the height SFM and

friction LFM for the 48-hour incubation period, the ethylene glycol-terminated areas were lighter
. Under these experimental conditions, it appeared that while the Aβ protein adsorbed mainly on
the HS(CH2)17CH3, it also migrated to the HS(CH2)11(OCH2CH2)3OH monolayer as was seen on
the small scale pattern. These results indicated that the spacing of the monolayers was not the
culprit of the protein deposition onto the ethylene glycol-terminated monolayer on the smaller
pattern.

HS(CH2)17CH3

HS(CH2)11(OCH2CH2)3OH

Figure 4.6. 20 μm x 20 μm scanning force micrographs of a patterned monolayer exposed
to 100 μM beta amyloid in 10 mM KOH solution at pH 11 for 48 hours. The height image is
on the left and the friction image is on the right. In the friction image the
HS(CH2)11(OCH2CH2)3OH monolayer is shown in the lighter areas. The Z-range is 50 nm
for the height image and 1.0 V for the friction image.

4.6

Deposition of Bovine Serum Albumin on a Patterned Monolayer
In order to determine the effect of the patterned monolayer on another protein,

experiments were repeated using bovine serum albumin (BSA) as a control.
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BSA is a

homogenous, sticky protein commonly used to test surfaces for fouling properties.19-21 The
small- and large-scale patterned substrates were constructed as described previously and the BSA
protein solution (100 μM in 15 mM PBS) was allowed to incubate on the patterned monolayers
for 12- and 48-hour intervals.
The results of incubating the BSA protein on a small-scale patterned monolayer (5 μm
and 2 μm stripes) for 48 hours are shown in Figure 4.7. On this surface, the BSA protein
remained confined to the fouling HS(CH2)17CH3 monolayer surface, unlike the Aβ protein
experiments under the same conditions. There was a minute amount (~ 0.6 aggregates per μm2)
of BSA aggregates present on the HS(CH2)11(OCH2CH2)3OH surface.

HS(CH2)11(OCH2CH2)3OH

HS(CH2)17CH3

Figure 4.7. 10 μm x 10 μm scanning force micrographs of a patterned monolayer exposed
to 100 μM bovine serum albumin in 15 mM PBS solution at pH 11 for 48 hours. The height
image is on the left and the friction image is on the right. In the friction image the
HS(CH2)11(OCH2CH2)3OH monolayer is shown in the lighter areas. The Z-range is 50 nm
for the height image and 0.5 V for the friction image.

The results of incubating the BSA protein on the large-scale substrate for 12 hours are
shown in Figure 4.8. The BSA protein appeared to only adsorb on the methyl-terminated areas
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of the substrate. After 48 hours (Figure 4.10), the deposition of the BSA protein was mostly
limited to the methyl-terminated areas of the substrate although the deposition of BSA protein
had branched onto the ethylene glycol-terminated areas. The patterned edges were still easily
discernable, which indicates that the BSA protein adsorbed mainly on the methyl-terminated
surface.

In this case, the BSA protein behaved as expected in regards to fouling on the

monolayers, even on the small scale pattern. This indicates that mixing of the monolayers did
not occur because the BSA protein would have adsorbed on the mixed monolayers.22,

23

Therefore, it was assumed that mixing of the monolayers also did not occur on the patterned
monolayer substrate used in the Aβ protein and that the Aβ protein actually attached on the
surfaces with small-scale pattern.

Figure 4.8. 81 μm x 81 μm scanning force micrographs of a patterned monolayer exposed
to 100 μM bovine serum albumin in 15 mM PBS solution at pH 11 for 12 hours. The height
image is on the left and the friction image is on the right. In the friction image the
HS(CH2)11(OCH2CH2)3OH monolayer is shown in the lighter areas. The Z-range is 50 nm
for the height image and 1.0 V for the friction image.
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HS(CH2)11(OCH2CH2)3OH

HS(CH2)17CH3

Figure 4.9. 33 μm x 33 μm scanning force micrographs of a patterned monolayer exposed
to 100 μM bovine serum albumin in 15 mM PBS solution at pH 11 for 48 hours. The height
image is on the left and the friction images are on the right. In the friction image the
HS(CH2)11(OCH2CH2)3OH monolayer is shown in the lighter areas. The Z-range is 50 nm
for the height image and 1.0 V for the friction image.

4.7

Incubation of Beta Amyloid Supernatant from the HS-(CH2)17-CH3 Monolayer on
the HS(CH2)11(OCH2CH2)3OH monolayer
Because the deposition of Aβ protein on the patterned monolayers was probably not due

to mixing of the monolayers, it was thought that the HS(CH2)17CH3 monolayer induced a change
in protein conformation that allowed Aβ protein to adsorb to the HS(CH2)11(OCH2CH2)3OH
monolayers. In order to test this hypothesis, Aβ protein in 10 mM KOH at pH 11.5 was first
incubated on the HS(CH2)17CH3 monolayer for 12 hours. The Aβ protein supernatant was
removed

from

the

HS(CH2)17CH3

monolayer

on

Au

and

applied

to

the

HS(CH2)11(OCH2CH2)3OH/Au substrate. The Aβ protein solution was then incubated on the
HS(CH2)11(OCH2CH2)3OH monolayer for 12 hours, then the monolayer was rinsed and analyzed
with RAIRS. Surprisingly, after incubation on the HS(CH2)17CH3 monolayer, the Aβ protein
adsorbed to the surface of the HS(CH2)11(OCH2CH2)3-OH monolayer (Figure 4.10). After
curve-fitting deconvolution was performed on the spectrum, it was confirmed that Aβ protein
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was present only in a β-sheet conformation. The resolved peaks were located at 1612, 1629,
1639, 1673, and 1695 cm-1. The peak at 1612 cm-1 is attributed to side chain interactions, while
the remaining peaks are indicative of β-sheet structures.

Therefore, the HS(CH2)17CH3

monolayer had the ability to induce a conformation that was able to adsorb to the previously nonfouling HS(CH2)11(OCH2CH2)3OH monolayer. Taken in relation to the patterned monolayer
experiments, it can be concluded that the small areas of fouling HS(CH2)17CH3 monolayer had
the ability to produce a class of Aβ protein that was folded in a way that allowed it to attach to
the HS(CH2)11(OCH2CH2)3OH monolayer.
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Figure 4.10. Curve-fitting deconvolution of RAIR spectrum of supernatant of 100 μM Aβ
in 10 mM KOH (pH 11.5) that was first incubated on HS-(CH2)17-CH3/Au for 12 h then
removed and incubated on the HS(CH2)11(OCH2CH2)3OH monolayer for 12 hours.
Original spectra (solid), fitted curve (dash-dot), and individual Gaussian components (dot)
with a reduced χ2 value of 3.09.
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Although ethylene glycol end groups are usually seen to be non-fouling, there are a few
examples in literature that show protein to be attracted to ethylene glycol functionalities.
Leckband et al. discovered that if streptavidin was forced into contact with a poly(ethylene
glycol) chain, there existed reasonably strong attractive forces between the protein and the
poly(ethylene glycol) moiety.24 It has also been shown that mucin, glycoproteins that line the
gastrointestinal tract, adhere weakly to poly(ethylene glycol).25 Therefore, it is not unreasonable
that the Aβ protein would adsorb to the HS(CH2)11(OCH2CH2)3OH monolayer.
4.8

Effects of a Patterned Monolayer on the Aggregation of Beta Amyloid Protein in
Solution
Previous studies (Chapter 3) indicated that the Aβ protein can adsorb on a fouling

monolayer, form larger aggregates and then desorb from the surface into solution where it acts as
a nucleus for further aggregation in solution. In the earlier studies analyzing the seeding effect
of the monolayers, the alkanethiol monolayer induced the aggregation of the protein in solution,
while the ethylene glycol-terminated monolayer did not affect the aggregation of the protein in
solution.

Therefore, the effect of the combination of the surface fouling and non-fouling

moieties on the aggregation of the protein in solution was also analyzed. A comparison between
the Aβ supernatant from the HS(CH2)17CH3 and the ethylene glycol-terminated monolayers and
the patterned monolayers was conducted using scanning force microscopy. The Aβ protein
solution was taken off the monolayer surfaces, applied to mica, allowed to adsorb for five
minutes, then rinsed and analyzed with SFM. A high pH solution was used to impede the
aggregates from forming in the solution.
The results of the Aβ peptide solution taken from the ethylene glycol-terminated
monolayer are displayed in Chapter 3, Figure 3.6. Following incubation on the monolayer
surface for 7 days, the solution had very few aggregates (approximately five aggregates per 100
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μm2), with lengths ranging from 25 to 30 nm and heights of approximately 10 nm. After a 7-day
incubation of the Aβ solution with the HS(CH2)17CH3 monolayer, the Aβ protein had formed
many more aggregates (approximately 55 aggregates per 100 μm2) in solution than did the
sample from the HS(CH2)11(OCH2CH2)3OH monolayer. The aggregates were approximately
100 to 120 nm long and had heights of approximately 50 nm (Figure 4.11A).
The solution from the patterned monolayers was analyzed in order to probe the effects of
the patterned monolayer on the production of the Aβ aggregates in solution. After 7 days of
incubation, the Aβ protein had formed larger aggregates approximately 35 nm in height and 75 to
90 nm in length (Figure 4.11B) with a population of approximately 50 aggregates per 100 μm2.

A.

B.

Figure 4.11. 10 μm x 10 μm scanning force micrographs of 100 μM Aβ10-35 peptide in 10
mM KOH solution at pH 11.5. A. Supernatant from the HS-(CH2)17-CH3 /Au monolayer
exposed to 100 μM Aβ10-35 peptide in 10 mM KOH for 7 days. B. Supernatant from the
HS-(CH2)17-CH3 and HS(CH2)11(OCH2CH2)3OH patterned monolayer exposed to 100 μM
Aβ10-35 peptide in 10 mM KOH for 7 days. For the supernatant experiments, 50 μL of
supernatant was spotted on mica, allowed to sit for 5 minutes, and then the resulting
surface was rinsed with 18 MS-cm water and dried. Z-range=50 nm.

After comparing the analysis of the Aβ solutions from all three surfaces, it was clear that
the Aβ solution from the patterned monolayers favored the aggregation activities of the solution

72

from the HS(CH2)17CH3 monolayer rather than the solution from the HS(CH2)11(OCH2CH2)3OH
monolayer. The Aβ solution from the HS(CH2)17CH3 monolayer experiment had a much greater
extent of peptide aggregation than the HS(CH2)11(OCH2CH2)3OH monolayer, as judged by
aggregation length and number. In comparison, the Aβ protein solution taken from the patterned
monolayer made up of both the HS(CH2)17CH3 and the HS(CH2)11(OCH2CH2)3OH monolayers
exhibited protein aggregation that was comparable to the HS(CH2)17CH3 monolayer. It can be
concluded that even small amounts of the HS(CH2)17CH3 in the patterned monolayers do induce
aggregation of the Aβ peptide in solution to the same extent that the monolayer surface made
entirely of HS(CH2)17CH3 did.
4.9

Conclusions
When the Aβ protein was incubated on a small-scale pattern of the fouling and non-

fouling monolayers, it appeared that the Aβ protein adsorbed onto the ethylene glycol even
though the ethylene glycol-terminated monolayers alone were previously seen to be non-fouling.
Since the Aβ protein was present on the ethylene glycol-terminated portion of the monolayer, it
appeared that the adsorptive characteristics of the methyl-terminated monolayer were greater
than the protein-resistant properties of the ethylene glycol-terminated monolayer. It seemed that
the Aβ protein nucleated on the fouling monolayer, then desorbed from the fouling monolayer
and readsorbed on the non-fouling monolayer surface. On the large-scale patterned monolayer,
it appeared that the Aβ protein did adsorb on the HS(CH2)17CH3, and migrated to the
HS(CH2)11(OCH2CH2)3OH monolayer although not to the extent that was seen on the small scale
pattern. A possible reason that there was less protein present on the larger-scale pattern than the
small-scale pattern could be that after the Aβ protein desorbed from the surface, the protein did
not travel far before it readsorbed on the surface; therefore, the length of diffusion of the protein
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was not great. On the large-scale pattern monolayer configuration, the domain constraints of the
surface have more of an effect on the deposition of the protein on surfaces.

When the Aβ

protein was first incubated on the HS(CH2)17CH3 monolayer alone, removed and then incubated
on the HS(CH2)11(OCH2CH2)3OH

monolayer, the protein adsorbed on the HS(CH2)11-

(OCH2CH2)3OH monolayer. This was surprising because when the freshly-made Aβ protein
was incubated on the HS(CH2)11(OCH2CH2)3OH monolayer, the HS(CH2)11(OCH2CH2)3OH
monolayer was non-fouling for up to 40 days. This was important because it appears that the
HS(CH2)17CH3 monolayer can induce a change in conformation that allows the protein to attach
to what are normally non-fouling surfaces. When analyzing the BSA protein on the patterned
surface, the protein behaved as expected in regards to fouling on the monolayers, even on the
small-scale pattern.
The effect of the patterned monolayer on the aggregation of the Aβ protein in solution
was investigated. It was clear that the Aβ solution from the patterned monolayers favored the
aggregation behavior of the Aβ solution from the HS(CH2)17CH3 monolayers rather than the Aβ
solution from the HS(CH2)11(OCH2CH2)3OH monolayer.

The Aβ solution from the

HS(CH2)17CH3 monolayer experiment had a much greater extent of peptide aggregation than the
HS(CH2)11(OCH2CH2)3OH monolayer, as judged by aggregation length and number.

In

comparison, the Aβ protein solution taken from the patterned monolayer made up of both the
HS(CH2)17CH3 and the HS(CH2)11(OCH2CH2)3OH monolayers exhibited protein aggregation
that was comparable to the HS-(CH2)17-CH3 monolayer. It can be concluded that even small
areas of fouling monolayer embedded in a non-fouling monolayer can induce aggregation of the
Aβ peptide in solution. This is important because it establishes that in the brains of humans it is
possible that a particular type of isolated chemical functionality on the cell membrane can act as

74

a nucleation site for inducing aggregation of Aβ protein on a surface that would not usually
affect the Aβ protein.
4.10
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Chapter 5
Interaction of Beta Amyloid Protein with Lipid Bilayers

5.1

Introduction
There is evidence that Aβ fibril assembly is effected by interactions with biological

surfaces by inducing β sheet aggregation.1-3 In addition, it has been shown that the presence of
negatively charged lipid vesicles in Aβ solutions shifts the random coil conformation of Aβ
peptide to a β–sheet conformation under conditions of low ionic strength.1, 2 This is due to the
electrostatic binding of Aβ peptide onto the lipid membrane surface and subsequent aggregation
of the peptide.3 Consequently, it is possible that some type of moiety on the cell surface triggers
the folding of Aβ peptide and subsequent plaque formation.
It has also been proposed that the toxicity of the Aβ protein is due to the interactions it
has with the cell membranes. The toxicity is possibly caused by the formation of ion channels
when the Aβ protein inserts into the cell membrane, which would disrupt the homeostasis of the
cell, leading to cell death.4-6 Since the Aβ peptide is cleaved from the Aβ precursor protein
within the cell membrane, it is possible that the Aβ peptide inserts itself back into the cell
membrane after cleavage.

The Aβ peptide would then be attached to the cell membrane,

providing a nucleus for subsequent protein aggregation.

Therefore, it is critical to investigate

the interaction of Aβ peptide and model membranes with each other. Lipid bilayers were chosen
to represent the cell membranes.
The goal of the work described here is an understanding of the effects of lipid membranes
on the aggregation of beta amyloid (Aβ) peptide and the effect of the Aβ peptide on the lipid
bilayer.

Mica-supported lipid bilayers consisting of 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-
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Phosphocholine

(POPC)

and

1-Oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]

dodecanoyl]-sn-Glycero-3-Phosphocholine (NBD-PC) were used as a model cell membrane
system. Lipid bilayers are physiologically significant because phospholipids are the principle
components of cellular membranes and POPC is one of the main elements of mammalian cell
membranes.7, 8 These model surfaces were used to determine the effect of the lipid bilayers on
the binding, deposition, and aggregation of the Aβ peptide.

Fluorescence photobleaching

recovery (FPR), fluorescence microscopy, and in situ scanning force microscopy (SFM) were
chosen to evaluate the effect of Aβ protein on the lipid bilayers.
5.2

Composition of Fluorescently Labeled Lipid Bilayers
Small, unilamellar lipid vesicles were constructed using the Morrissey protocol and were

subsequently adsorbed onto mica substrates using vesicle fusion to form the lipid bilayers.9, 10
The lipid bilayers were first analyzed using fluorescence microscopy (Figure 5.1). The image
shows a surface that has some wavelike patterns with higher fluorescence intensity that is
attributed to the fact that the lipid bilayer was moving even when the image was being obtained.
The camera captured the movement and produced these patterns. This image indicated that a
lipid bilayer was formed using this method.

Figure 5.1. Fluorescence microscopy image of 5% NBD-PC / 95% POPC lipid bilayer on
mica.
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Figure 5.2. Fluorescence photobleaching recovery of 100% NBD-PC lipid bilayer on mica
that was not rinsed after lipid bilayer formation. The diffusion coefficient was found to be
6.63 x 10-8 ± 3.08 x 10-9 cm2s-1.

Initial analysis was done using lipid bilayers made with different proportions of POPC
and NBD-PC to determine the correct ratios of the two lipids and the correct method for making
the lipid bilayers.

Preliminary analysis was performed using 100% NBD-PC vesicles in

phosphate buffer solution to determine the diffusion coefficient of the lipid bilayers. In the first
experiment, the lipid bilayers were fused onto the mica surface and analyzed without rinsing the
surface after the bilayer had formed (Figure 5.2). The diffusion coefficient was calculated to be
6.63 x 10-8 ± 3.08 x 10-9 cm2s-1. Next, the bilayers were formed and they were then rinsed with
phosphate buffer solution after the bilayer had formed in order to remove any unadsorbed lipid
vesicles (Figure 5.3). After the lipid bilayers were analyzed, the diffusion coefficient was
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calculated to be 6.65 x 10-8 ± 7.17 x 10-9 cm2s-1, which was comparable to the unrinsed lipid
bilayers.
Since the NBD-PC lipids do not exist in nature and a high concentration of a fluorescent
label can cause quenching that leads to errors in the diffusion coefficient, a mixture of POPC and
NBD-PC was used. Initial concentrations were 20% NBD-PC and 80% POPC. This mixture
produced a totally quenched sample that had no fluorescence signal. Next, a 10% NBD-PC and
90% POPC mixture was used that also produced a quenched sample.
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Figure 5.3. Fluorescence photobleaching recovery of 100% NBD-PC lipid bilayer on mica
that was rinsed after bilayer formation. The diffusion coefficient was found to be 6.65 x
10-8 ± 7.17 x 10-9 cm2s-1.
Finally, a 5% NBD-PC and 95% POPC sample was made that produced a viable
fluorescence signal. After the lipid bilayer was formed on mica, the sample was rinsed with
phosphate buffer solution to eliminate any nonfused lipid vesicles. Analysis was done using
FPR to obtain the diffusion coefficient (Figure 5.4).
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The diffusion coefficient from these

experiments was 5.99 x 10-8 ± 5.51 x 10-9 cm2s-1, which was comparable to the 100% NBD-PC
lipid bilayer sample.
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Figure 5.4. Fluorescence photobleaching recovery of 5% NBD-PC / 95% POPC lipid
bilayer on mica that was rinsed after bilayer formation. The diffusion coefficient was 5.99
x 10-8 ± 5.51 x 10-9 cm2s-1.
5.3

Analysis of the Formation of Fluorescently Labeled Lipid Bilayers with In Situ
Scanning Force Microscopy

The formation of the lipid bilayers from lipid vesicles was analyzed using in situ SFM. Figure
5.5 depicts the topography of the 5% NBD-PC / 95% POPC lipid bilayer surfaces during their
formation on a mica support. Initially, the surface had a lamellar structure with completely
planar layers. The thickness was considerably higher (~ 40 nm) than that of a typical POPC lipid
bilayer (Figure 5.2A).11 After approximately 12 minutes, (Figure 5.2B) the lipid bilayer had
formed with a few defects. Before the lipid bilayer was rinsed, there were a few nonfused
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vesicles present on the surface (Figure 5.2C). After the lipid bilayer surface was rinsed with
phosphate buffer solution, the lipid bilayer had very few surface defects.

A.

B.

C.

D.

Figure 5.5. In situ scanning force microscopy images of lipid vesicles (5% NBD-PC / 95%
POPC in phosphate buffer solution) forming a lipid bilayer on a mica surface. A. Initial
image of lipid vesicles on mica. Z-range = 50 nm. B. Lipid bilayer begins to form after 4
minutes deposition time. Z-range = 100 nm C. Nonfused lipid vesicles on the lipid bilayer
surface before rinsing. Z-range = 50 nm. D. Lipid bilayer after rinsing with phosphate
buffer solution. Z-range = 20 nm.
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Following the formation of the supported lipid bilayer, analysis was done to determine
the thickness of the bilayer. A high tip force (deflection setpoint = 10 V) was used to scrape
away the bilayer while scanning in a 3 μm x 3 μm area. After four scanning cycles, the tip force
was reduced to a normal force (deflection setpoint = 2 V) and the scanning area was enlarged to
10 μm x 10 μm, which allowed for imaging of the bare area in the lipid bilayer so that a depth
profile analysis could be performed (Figure 5.6A). Section analysis was performed to create a
height profile of the lipid bilayer (Figure 5.6B). The thickness of the bilayer was approximately
six nm, which corresponded to literature values which were six nm.11

B.

A.

Figure 5.6. A. In situ scanning force microscopy image of 5% NBD-PC / 95% POPC lipid
bilayer on mica. A high tip scanning force was used to scrape away the bilayer and then
the scanning area was enlarged using a normal tip scanning force for a depth profile
analysis. B. Height profile of the lipid bilayer; the thickness of the bilayer is
approximately six nm. Z-range = 10 nm.
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5.4

Interaction of Beta Amyloid Peptide with Lipid Bilayers
To determine if the Aβ peptide interacted with the lipid bilayers, thioflavin-T-labeled 100

μM Aβ10-35 peptide fibrils were incubated for one hour on a 100% POPC lipid bilayer supported
on mica. Thioflavin-T is a fluorescent dye that binds to the hydrophobic core of the Aβ protein
and allows the Aβ peptide to be imaged with a fluorescence microscope. The preformed Aβ
fibrils were approximately 25 μm in length. After the exposure time was complete, the lipid
bilayer was rinsed with phosphate buffer solution. Initial analysis was done using fluorescence
microscopy (Figure 5.7). The Aβ peptide fibrils appeared to have a strong interaction with the
lipid bilayers since the fibrils were still present on the surface even after rinsing.

Figure 5.7. Fluorescence microscopy image of 100% POPC lipid bilayer on mica exposed
to preformed, thioflavin-T labeled 100 μM Aβ10-35 peptide fibrils for one hour.
FPR analysis was done to determine the effect of the Aβ protein fibrils on the fluidity of
the lipid bilayers. Preformed Aβ1-40 protein fibrils were incubated on the 5% NBD-PC / 95%
POPC lipid bilayers over a period of five hours (Figure 5.8). During this time, the diffusion
coefficient of the lipid bilayers decreased from 5.99 x 10-8 cm2 s-1 to 8.3 x 10-9 cm2 s-1, indicating
that the Aβ protein interacted with the lipid bilayers. It is thought that the Aβ protein fibrils
interacted with the lipid bilayers because the hydrophobic areas of the Aβ protein were attracted
to the interior hydrophobic tail regions of the lipid bilayer.
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The interaction of the Aβ peptide with the lipid bilayers was also monitored with in situ
scanning force microscopy.

The 5% NBD-PC / 95% POPC lipid bilayer was formed as

described previously and imaged to ensure that a defect-free surface had formed. The freshlymade Aβ10-35 peptide was then added to the lipid bilayer. Perturbations began to form in the lipid
bilayer after approximately ten minutes. After approximately one hour, the Aβ peptide began to
insert into the lipid bilayer causing further defects in the surface (Figure 5.9). This is illustrated
by the presence of a Aβ peptide aggregate in the middle of a hole in the lipid bilayer. The Aβ
peptide appears to have caused pore-like defects in the lipid bilayer surface. It should be noted
that when the lipid bilayer was imaged with a Aβ peptide-free phosphate buffer solution (control)
no defects formed in the surface for comparable incubation times.
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Figure 5.8. Diffusion coefficient of preformed beta amyloid
NBD-PC/ 95% POPC lipid bilayer on mica over time.
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Figure 5.9. In situ scanning force microscopy image of 5% NBD-PC / 95% POPC lipid
bilayer on mica exposed to: A. 15 mM phosphate buffer solution for one hour; B. 100 μM
Aβ10-35 peptide (in phosphate buffer solution) for one hour; C. Zoom image of 100 μM Aβ1035 peptide (in phosphate buffer solution) for one hour; D. Height profile of the lipid bilayer
and beta amyloid protein aggregate. Z-range = 50 nm.
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5.5

Interaction of Nystatin with Lipid Bilayers
For comparison purposes, the interaction of nystatin, an antimicrobial agent, with the

lipid bilayer system was examined. Nystatin, which is used as an antifungal medicine, is known
to insert into lipid bilayers.12-14 The nystatin (10 μM in 15 mM phosphate buffer solution) was
applied to a 5% NBD-PC / 95% POPC lipid bilayer and allowed to incubate for 24 hours. The
surface was rinsed with phosphate buffer and imaged using in situ contact mode SFM. It
appeared that the nystatin attached to the lipid surface and disrupted the lipid membrane. The
nystatin aggregates were 500 nm in length and 25 nm in height. When compared to the results of
the Aβ peptide, it appeared that the Aβ peptide disrupted the lipid bilayer more than the nystatin
did, giving evidence that the Aβ peptide can form ion pores.

B.

A.

Figure 5.10. In situ scanning force microscopy image of 5% NBD-PC / 95% POPC lipid
bilayer on mica exposed to 10 μM nystatin (in 15 mM phosphate buffer solution) for 24 h.
B. Zoom view of Figure 5.10A. Z-range = 50 nm.
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5.6

Effect of Lipid Bilayers on the Aggregation of Beta Amyloid Peptide
The effect of the lipid bilayers on the aggregation of the monomeric Aβ10-35 peptide was

analyzed. The Aβ peptide was dissolved in KOH solution with a high pH (pH ~ 11.5) to prevent
aggregation. The Aβ peptide was incubated on the 5% NBD-PC / 95% POPC lipid bilayers.
The Aβ peptide solution was removed from the lipid bilayer surface and applied to mica, which
allows for the solution phase deposition of protein. The samples were then analyzed using SFM.
After a 48-hour incubation time (Figure 5.10A) large, amorphous protein aggregates had formed
B.

A.

Figure 5.11. In situ scanning force microscopy images of supernatant from lipid bilayer
from the 5% NBD-PC / 95% POPC lipid bilayer on mica exposed to 100 μM Aβ10-35 peptide
in 10 mM KOH solution at pH 11.5 for 48 hours; Z-range = 100 nm (A). Supernatant from
lipid bilayer from the 5% NBD-PC / 95% POPC lipid bilayer on mica exposed to 10 mM
KOH solution at pH 11.5 for 48 hours; Z-range = 10 nm (B). 50 μL of supernatant was
spotted on mica, allowed to sit for 5 minutes, and then the resulting surface was rinsed with
18 MΩ-cm water and dried.

in solution. A control consisting of a Aβ peptide-free KOH solution incubated on a lipid bilayer
for the same amount of time and the applied to mica was used for comparison (Figure 5.10B).
This sample had none of the large structures characteristic of the Aβ peptide solution. Therefore,
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it can be concluded that the large, amorphous structures that resulted when the Aβ peptide
solution was incubated on the lipid bilayer are truly Aβ peptide and not portions of the lipid
bilayer that has disassembled because of the KOH (control) solution.
5.7

Conclusions
The interaction of the Aβ peptide the lipid bilayers was analyzed using FPR and in situ

SFM. FPR was used to monitor the fluidity of the bilayers. The baseline fluidity of the lipid
bilayers was established, and then the Aβ protein was incubated on the bilayers.

It was

demonstrated that the fluidity of the lipid bilayers was reduced when incubated with Aβ peptide,
indicating that there was an interaction with the lipid bilayers and the protein. The interaction of
the protein with the bilayer was further analyzed with in situ SFM. The in situ SFM revealed
that the Aβ peptide actually physically disrupted the lipid bilayers causing pores to form in the
lipid bilayers. It is thought that the hydrophobic groups of the Aβ peptide interact with the
hydrophobic inner areas of the lipid bilayer. This is a useful model of the cytotoxicity of the
protein, because if pores formed, they would act as ion channels. These ion channels would
disrupt the cellular homeostasis, which would lead to cell death.4
The Aβ protein solution that was incubated on the lipid bilayers was also examined. The
solution showed evidence of extensive Aβ peptide aggregation, indicating that the lipid bilayers
induced aggregation of the peptide in solution. This information is important because it provides
evidence about the formation of amyloid plaques in the brains of humans. It is possible that the
Aβ protein inserts into the lipid bilayer and is immobilized where it can act as a seeding nucleus
for further aggregation of the protein to form.
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Chapter 6
Outcomes, Conclusions and Future Direction

6.1

Summary of Outcomes and Conclusions

6.1.1

Surfaces Can Induce Aggregation of Beta Amyloid Peptide in Solution
Reflection-absorption infrared spectroscopy (RAIRS) analysis revealed that adsorption of

Aβ occurred onto both hydrophilic and hydrophobic surfaces under conditions that normally do
not lead to aggregation in solution. In addition, the RAIRS studies demonstrated that the
conformation of the adsorbed Aβ10-35 does not change over a period of 40 days of exposure, and
the amount of Aβ deposited increases with exposure time. Scanning force microscopy (SFM)
confirmed that the amount of aggregated deposits increased with exposure time. Studies of the
solutions exposed to monolayers revealed that the monolayers have a seeding effect on Aβ
peptide in solution, leading to the conclusion that monolayers actually induce aggregation of Aβ
peptide in solution.
6.1.2

Adsorptive Behavior and Aggregation Properties of Beta Amyloid Peptide on
Patterned Surfaces
Patterned

surfaces

made

up

of

fouling

(HS(CH2)17CH3)

and

non-fouling

(HS(CH2)11(OCH2CH2)3OH) monolayers were constructed to determine how these different
areas would affect the aggregation and adsorption of the Aβ protein. When the Aβ protein was
incubated on a small-scale pattern (~ 1 μm repeat pattern) of the fouling and non-fouling
monolayers, it appeared that the Aβ protein adsorbed onto the ethylene glycol even though the
ethylene glycol-terminated monolayers alone were previously seen to be non-fouling. Because
the Aβ protein was present on the ethylene glycol-terminated portion of the monolayer, it seemed
that the adsorptive characteristics of the methyl-terminated monolayer were greater than the
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protein-resistant properties of the ethylene glycol-terminated monolayer. It appeared that the Aβ
protein nucleated on the fouling monolayer, then desorbed from the fouling monolayer and
readsorbed on the non-fouling monolayer surface. On the large-scale patterned monolayer (~ 1030 μm repeat pattern), it appeared that the Aβ protein adsorbed mainly on the HS(CH2)17CH3, but
also adsorbed on the HS(CH2)11(OCH2CH2)3OH monolayer although not to the extent that was
seen on the small scale pattern. It was determined that the HS(CH2)17CH3 monolayer must alter
the Aβ protein in such a way that allows it to adsorb to the HS(CH2)11(OCH2CH2)3OH
monolayer. In order to test this theory, the Aβ protein was first incubated on the HS(CH2)17CH3
monolayer alone, removed and then incubated on the HS(CH2)11(OCH2CH2)3OH monolayer
alone. Subsequently, the Aβ protein adsorbed on the HS(CH2)11-(OCH2CH2)3OH monolayer.
This was surprising because when freshly-made Aβ protein was incubated on the
HS(CH2)11(OCH2CH2)3OH monolayer, the HS(CH2)11(OCH2CH2)3OH monolayer was nonfouling for up to 40 days. This was important because it appears that the HS(CH2)17CH3
monolayer can induce a change in conformation that allows the protein to stick to what are
normally non-fouling surfaces.
The effect of the HS(CH2)17CH3 / HS(CH2)11-(OCH2CH2)3OH patterned monolayer on
Au on the aggregation of the Aβ protein in solution was investigated. It was clear that the Aβ
solution from the patterned monolayers favored the aggregation behavior of the solution from the
HS(CH2)17CH3 monolayers rather than the solution from the HS(CH2)11(OCH2CH2)3OH
monolayer. The Aβ solution from the HS(CH2)17CH3 monolayer experiment had a much greater
extent of peptide aggregation than the HS(CH2)11(OCH2CH2)3OH monolayer, as judged by
aggregation length and number gain from the SFM experiments. In comparison, the Aβ protein
solution taken from the patterned monolayer made up of both the HS(CH2)17CH3 and the
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HS(CH2)11(OCH2CH2)3OH monolayers exhibited protein aggregation that was comparable to the
HS-(CH2)17-CH3 monolayer. It can be concluded that even small areas of fouling monolayer
embedded in a non-fouling monolayer can induce aggregation of the Aβ peptide in solution.
This is important when a parallel is made between this study and physiological circumstances. If
there are small areas of chemically different of damaged cell membranes in the human brain,
normally insoluble Aβ peptide may be conformationally changed to a type of protein that can
attach to normal areas of the brain and form plaques.
6.1.3

Interaction of Beta Amyloid Peptide with Lipid Bilayers
The interaction of the Aβ peptide with lipid bilayers was analyzed using fluorescence

photobleaching recovery (FPR) and in situ SFM. FPR was used to monitor the fluidity of the
bilayers by photobleaching areas of the fluorescent bilayer sample and recording the lateral
motion as the bleached areas mix with the unbleached areas. The baseline fluidity of the lipid
bilayers was established, and then the Aβ protein was incubated on the bilayers.

It was

demonstrated that the diffusion coefficient of the lipid bilayers was reduced when incubated with
Aβ peptide, which indicated that there was an interaction between the lipid bilayers and the
protein. The interaction of the protein with the bilayers was further analyzed with in situ SFM
and revealed that the Aβ peptide actually physically disrupted the lipid bilayers and caused pores
to form in the lipid bilayers. It is probable that the hydrophobic groups of the Aβ peptide interact
with the hydrophobic inner areas of the lipid bilayer, which causes the Aβ peptide to insert itself
into the lipid bilayer. This is a useful model of the cytotoxicity of the protein, because if pores
formed in a cell membrane, they would act as ion channels. These ion channels would disrupt
the cellular homeostasis, which could lead to cell death.1
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The Aβ protein solution that was incubated on the lipid bilayers was also examined. The
solution showed evidence of extensive Aβ peptide aggregation, indicating that the lipid bilayers
induced aggregation of the peptide in solution. This information is important because it provides
evidence about the formation of amyloid plaques in the brains of humans. It is possible that the
Aβ protein inserts into the lipid bilayer and is immobilized where it can act as a seeding nucleus
for further aggregation of the protein to form.
6.2

Future Directions

6.2.1

Interaction of Lipids with Known Inserting Proteins
It was seen that the Aβ protein inserted into lipid bilayers under certain experimental

conditions.2, 3 For comparison purposes, the interaction of other proteins with the lipid bilayer
system describe here should be examined. Several antimicrobial proteins, such as protegrin-1,
are known to insert into lipid bilayers.4-12 It has been well documented that this protein inserts
into lipid bilayers and membranes, and it would be helpful to examine protegrin-1 under the
same conditions as the Aβ protein was studied for comparison purposed. It would also be useful
to inspect the interaction of the amylin protein with the lipid bilayers. Amylin is a protein
associated with Type 2 Diabetes and is similar in structure to the Aβ protein.13, 14 It has been
shown that the amylin protein inserts into lipid bilayers and vesicles, therefore it could be
compared with the insertion of the Aβ protein into lipid bilayers.
It would also be helpful to study the interaction of Aβ protein with various other types of
lipids and different compositions of lipid membranes. Membranes with composed of mixtures of
anionic lipids, such as dipalmitoylphosphatidylglycerol, cationic lipids, such as dipalmitoyltrimethylammonium propane, and zwitterionic lipids, such as dipalmitoylphophatidylcholine,
should be analyzed.15, 16
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6.2.2

Interaction of Aggregation-Inhibitor Peptides with Lipid Bilayers
It has been confirmed that the inhibitor peptides synthesized by the Hammer Group

(AMY-X) can interact with the Aβ protein assembly.17-19 It is proposed that these inhibitors will
have an effect on the interaction of the Aβ protein with the lipid bilayers. It was seen previously
that the interaction of the Aβ protein with lipid bilayers affected the lipid bilayer fluidity and
physically disrupted the bilayers. It is possible that the AMY-X inhibitors will be able to curb
the interaction of Aβ protein with lipid membranes. This hypothesis should be studied using
FPR and in situ SFM. The fluidity of lipid membranes exposed to Aβ protein in the presence of
AMY-X will be examined using by FPR and the assembly will be imaged using in situ SFM.
6.2.3

Detection of Biomarkers for Alzheimer’s Disease
Microcontact printing has become a useful tool in the manufacture of microanalytical

devices, such as chemical and biological sensing devices. The evolution of cell and protein
arrays depends largely on developing techniques that control topographical features and spatial
presentation of surface molecules, such as microcontact printing. These arrays can be used for
drug discovery, diagnostic assays and biosensors. With the discovery of a biological marker for
the detection of Alzheimer’s disease,20 microanalytical devices can now be developed to detect
Alzheimer’s disease. Microcontact printing is a viable option for the construction of such
detection devices.
Patterning and immobilization of biologically active moieties with micrometer and
nanometer scale control has proven integral to a range of applications in basic research,
diagnostics and drug discovery. Future goals could be to capture Aβ protein in a specific
orientation using microcontact printing and then use for other applications such as high
throughput detection systems for drug development and for detection of Alzheimer’s disease. It
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is possible to orient the Aβ protein specifically so that a β-sheet conformation is produced while
maintaining the biomolecular behavior of the patterned Aβ protein. Detection systems that
employ the Aβ-specific antibody could also be developed using patterned monolayers.
6.3
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Appendix A
Deconvolution of Infrared Spectra
When infrared spectroscopy is performed on proteins that are oriented in different
secondary structures, the spectroscopic bands sometimes overlap, as is seen in the amide bands
of the Aβ peptide. When this happens, curve-fitting band deconvolution must be performed to
resolve the overlapped peaks that occur when two or more protein conformations are present.
Infrared spectroscopy works by inducing a molecular vibration in a molecule. Energy is
absorbed when the frequency of the radiation matches the frequency of the vibration of the
molecule and causes a transition where the molecule goes from the ground vibronic state to an
excited vibronic state; this results in the vibrational spectrum. After the molecules are excited,
they quickly return to the ground state. This relaxation is called the amplitude lifetime, τa. When
the transition initially occurs, all of the excited molecules vibrate simultaneously, but the
molecules begin to vibrate out of sequence with each other as difference in motion and
vibrational frequencies take over. This randomization is called the coherence lifetime, τc. As the
vibrations become chaotic, the components begins to interfere with each other and dephase,
giving rise to the effective lifetime, τ, which is a combination of the τa and τc components.1
Several factors must be determined when performing curve fitting. One of these is the
type of peak function to use. The type of function depends on the relationship between τa and τc.
When τc >> τa, the excited molecule relaxes before incoherence becomes significant and the IR
peak has a Gaussian shape.1 In this situation, a Gaussian function will resolve the overlapped
peaks the best. This function is given by the equation:

f (x) = He

⎛ x − x0
−⎜
⎜ w
⎝

2
⎞
⎟ (4 ln (2))
⎟
⎠

Equation A.1
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where x0 is the position (frequency) of the peak, H is the peak height (intensity), and w is the line
width which is given as the full width at half height value.2
When τc << τa, the incoherence happens quickly, and dephasing of the molecular
vibrations is prominent.1 The shape of these overlapped peaks is sharp in the center with long
wings sloping down from the center. A Lorentzian function will help resolve overlapped peaks
the best in this situation. This function is given by the equation:

f(x) =

H
x−x 2
0
4(
) +1
w

Equation A.2

The GRAMS32 program chooses the best fit based on the experimental relationship
between τa and τc. In the work described here, the Gaussian function was used to resolve the
peaks since τc >> τa.
Another parameter affecting the correctness of fit is the number of peaks present. Fit is
described by χ2, which is given by the following equation:

n ⎛ Actual i − Calculated
∑ ⎜⎜
RMS Noise
⎝
χ 2 = i =0
(n − f )

i ⎞⎟
⎟
⎠

2
Equation A.3

where the Actual and Calculated variables are the measured and calculated intensity data,
respectively, and the RMS Noise value is the estimated root mean squared noise in the actual
data.2 The value n-f is the number of degrees of freedom in the data set, where n is the number
of data points in the fitted region and f is the total number of variables from all the peak and
baseline functions.2 If too many peaks are chosen a better fit will be produced, but some of the
resolved peaks may be invented by the program to produce the fit. If too few peaks are chosen, a
peak that is actually present will not be resolved, and this will result in a poor fit. Therefore, a
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Fourier self-deconvolution (FSD) must be performed before the curve fitting process to
determine how many unresolved peaks are actually present. A Fourier transform (FT) is first
applied to the data:
∞

F ( x) = ∫ Ai (ν ) cos 2πν x dν

Equation A.4

0

= 0.5 Ai0 γ i cos(2πν i0 x) exp(−2πγ i x)

where the coefficient 0.5 Ai0γi is directly proportional to the area of the peak, the cosine term
depends on the center wavenumber of the peak, and the exponential decay term is the
deconvolution filter.3 An inverse FT function is then applied to the data to fully resolve the
spectrum. The inverse FT function is achieved by multiplying F(x) by exp(2πγ’x) to give the
new function, F’(x):
F ′( x) = F ( x) exp(−2πγ ′ x)
= 0.5 Ai0γ i cos(2πν i0 x) exp[− 2π (γ i − γ ′ ) x ]

Equation A.5

After the peaks are resolved, a goodness of fit parameter, χ2, is calculated. Typically, a χ2 value
less than 10 is deemed acceptable.2
To determine if the program worked accurately under the parameters that were set, a test
was done. Three peaks were made up using the Excel program. These peaks were added
together to produce a mock overlapped peak, as is shown in Figure A.1. The resulting peak was
imported into GRAMS/32 where the FSD and curve fitting functions were performed using the
Gaussian function to resolve the peaks. The results are depicted in Figure A.2. When the
starting data and the processed data are plotted in the same graph, the curve fitted peak match up
almost exactly (χ2 = 1.2) with the original peaks (Figure A.3). This proves the accuracy of the
GRAMS/32 program in resolving the overlapped peaks, provided the correct parameters are
used.
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Figure A.1. Peak created in Excel and added together to produce an imaginary overlapped
peak.
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Figure A.2. Peaks resulting from curve fitting and deconvolution of the imaginary
overlapped peak.

103

0.0016

Imaginary Peak 1
Imaginary Peak 2
Imaginary Peak 3
Peak Addition
Curve Fit Peak 1
Curve Fit Peak 2
Curve Fit Peak 3

Absorbance

0.0012

0.0008

0.0004

0.0000

1600

1575

1550

1525

1500

-1

Wavenumber (cm )

Figure A.3. Peaks created in Excel and added together to produce an imaginary
overlapped peak combined the peaks resulting from curve fitting and deconvolution of the
imaginary overlapped peaks.
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Figure A.4. Deconvoluted RAIR spectra of HS-(CH2)17-CH3/Au exposed to aqueous
solutions of 100 μM Aβ in 10 mM KOH (pH 11.5) for 15 h. Original spectra (dash), fitted
curve (dash-dot), and individual Gaussian components (dot) with a reduced χ2 value of 5.2.
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Figure A.5. Deconvoluted RAIR spectra of HS-(CH2)15-COOH/Au exposed to aqueous
solutions of 100 μM Aβ in 10 mM KOH (pH 11.5) for 15 h. Original spectra (dash), fitted
curve (dash-dot), and individual Gaussian components (dot) with a reduced χ2 value of
10.0.
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Figure A.6. Deconvoluted RAIR spectra of HS-(CH2)10-SO3H/Au exposed to aqueous
solutions of 100 μM Aβ in 10 mM KOH (pH 11.5) for 15 h. Original spectra (dash), fitted
curve (dash-dot), and individual Gaussian components (dot) with a reduced χ2 value of 2.0.
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Figure A.7. Deconvoluted RAIR spectra of HS-(CH2)11-OH/Au exposed to aqueous
solutions of 100 μM Aβ in 10 mM KOH (pH 11.5) for 15 h. Original spectra (dash), fitted
curve (dash-dot), and individual Gaussian components (dot) with a reduced χ2 value of 9.1.
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Figure A.8. Deconvoluted RAIR spectra of CF3-(CF2)7-(CH2)2-SH/Au exposed to aqueous
solutions of 100 μM Aβ in 10 mM KOH (pH 11.5) for 15 h. Original spectra (dash), fitted
curve (dash-dot), and individual Gaussian components (dot) with a reduced χ2 value of 5.3.
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Figure A.9. Deconvoluted RAIR spectra of CF3-(CF2)7-(CH2)2-SH/Au exposed to aqueous
solutions of 100 μM Aβ in 10 mM KOH (pH 11.5) for 7 days. Original spectra (dash), fitted
curve (dash-dot), and individual Gaussian components (dot) with a reduced χ2 value of 4.3.
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Figure A.10. Deconvoluted RAIR spectra of CF3-(CF2)7-(CH2)2-SH/Au exposed to aqueous
solutions of 100 μM Aβ in 10 mM KOH (pH 11.5) for 20 days. Original spectra (dash),
fitted curve (dash-dot), and individual Gaussian components (dot) with a reduced χ2 value
of 5.4.
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